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ABSTRACT 
Herbal medicines are an important part of the African culture and tradition and about 80% of 
Africa’s population relies on traditional remedies for their primary health care needs (WHO, 
2008).  Athrixia phylicoides is widely used as a traditional remedy, but despite its substantial 
use, literature on its chemical composition and biological activities is limited.  In this study, 
the chemical composition of the essential oil was determined using gas chromatography 
combined with mass spectroscopy (GC/MS) and analysis resulted in the identification of 182 
compounds.  The major compounds identified in selected samples were α-pinene, β-pinene, 
caryophyllene oxide, β-caryophyllene, myrcene and spathulenol.  Based on the traditional uses 
of A. phylicoides, various in vitro biological activities were investigated.  The extensive use of 
A. phylicoides for the treatment of boils, sores, bad acne, infected wounds and cuts, prompted 
the antimicrobial (bacterial and fungal) study using the minimum inhibitory concentration 
(MIC) assay.  The methanol extract and essential oil were more selective for the Gram-
positive bacteria than the Gram-negative bacteria.  The extract exhibited stronger activity 
against all micro-organisms tested compared to the essential oil, with the highest activity 
against S. aureus, B. cereus and B. subtilis (MIC = 1 mg/ml).  The bioactive compound,  
(4-hydroxyphenyl) propyl coumaroate was isolated from the extract and proved to be most 
active against S. aureus (MIC = 19.5 μg/ml). Using the DPPH• assay, a comparative anti-
oxidant study was performed.  The anti-oxidant activity of the aqueous extract of A. 
phylicoides (IC50 = 14.01 ± 2.68 µg/ml) was greater than rooibos and Ceylon (black) tea (IC50 
> 25.00 µg/ml); comparable to green rooibos and honeybush tea (IC50 = 18.01 ± 4.06 µg/ml; 
18.02 ± 4.27 µg/ml, respectively), but less active than green tea (IC50 = 9.64 ± 0.96 µg/ml).  
The antimalarial activity was determined using the [3H] hypoxanthine incorporation method.  
The essential oil exhibited greater antimalarial activity against the chloroquine-resistant 
Plasmodium falciparum (FCR-3) strain (IC50 = 1.006 ± 0.06 μg/ml) than the methanol extract.  
The 5-lipoxygenase assay was used to assess the anti-inflammatory activity of the methanol 
extract and essential oil.  Only the essential oil displayed anti-inflammatory activity (IC50 = 
25.68 µg/ml).  Low safety indices were reported for both the methanol extract (SI = 2.28) and 
essential oil (SI = 1.77).   The in vitro biological activities may validate the use of A. 
phylicoides in traditional medicine. 
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Chapter 1 – General introduction 
 
 
1.1 Medicinal plants and their place in our society 
“Medicinal plants are something of the future, not the past” (van Wyk et al., 2002). 
 
Herbal medicines are an important part of the culture and tradition of African people (Fennell 
et al., 2004).  The World Health Organisation (WHO) estimates that in some African 
countries, up to 80% of the population relies on traditional materia medica (medicinal plants) 
for their primary health care needs (WHO, 2008). 
 
Africa is a continent endowed with an enormous wealth of plant resources.  Southern Africa 
has well over 30 000 species of higher plants.  In South Africa, approximately 3 000 species 
have been used for several centuries as medicine for the prevention and treatment of diseases 
(van Wyk et al., 2002).  Some renowned African medicinal plants include Acacia senegal 
(gum Arabic), Agathosma betulina (buchu), Aloe ferox (Cape aloes), Artemisia afra (African 
wormwood), Aspalathus linearis (rooibos tea), Boswellia sacra (frankincense), Catha edulis 
(khat), Commiphora myrrha (myrrh), Harpagophytum procumbens (devil’s claw), Hibiscus 
sabdariffa (hibiscus or roselle), Hypoxis hemerocallidea (African potato) and Prunus africana 
(African cherry or red stinkwood) (van Wyk and Wink, 2004). 
 
It is believed that the profound knowledge of medicinal plants was developed through trial and 
error over several centuries and the most important remedies were passed on verbally from 
one generation to the next.  The founders and users of the medicinal plants may not have 
understood the scientific rationale behind the efficacy of these plants, but knew from personal 
experience that they were highly effective (van Wyk and Wink, 2004). 
 
History reveals that for centuries plants have been the main source of medicine for most 
cultures.  The long history of herbal medicine and the number of allopathic drugs derived from 
plant material (Table 1.1) is an indicator that medicinal plants are effective and can stimulate 
the discovery of new compounds for the treatment of new and old diseases. 
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Table 1.1:  Examples of active compounds isolated from plants. 
Plant Active compound Use/Action Literature source 
Aloe ferox 
 
Aloe emodin 
Chrysophanol 
Aloin 
Purgative Kambizi et al., 2004
Artemisia annua Artemisinin Antimalarial Clark, 1996 
Atropa belladonna Atropine Anticholinergic De Smet, 1997; 
Rates, 2001 
Camellia sinesis Theophylline 
Caffeine 
Bronchodilator  
CNS stimulant 
De Smet, 1997 
Cassia spp. Sennosides A&B Laxative De Smet, 1997 
Catharanthus roseus Vinblastine & 
Vincristine 
Antitumor De Smet, 1997; 
Rates, 2001 
Chondodendron 
tomentosum 
Tubocurarine Skeletal muscle 
relaxant 
De Smet, 1997 
Cinchona ledgeriana Quinine 
Quinidine 
Antimalarial 
Antiarrhythmic 
De Smet, 1997; 
Rates, 2001 
Colchicum autumnale Colchicine Anti-gout De Smet, 1997 
Digitalis purpurea Digoxin Cardiotonic De Smet, 1997; 
Rates, 2001 
Ephedra sinica Ephedrine Sympathomimetic De Smet, 1997 
Gaultheria procumbens Methyl salicylate Rubefacient De Smet, 1997 
Helichrysum cymosum Helihumulone Antibacterial and 
antifungal (yeasts)  
van Vuuren et al., 
2006 
Hyoscyamus niger Hyocyamine Anticholinergic De Smet, 1997 
Larrea divaricata Nordihydroguaiaretic 
acid 
Anti-oxidant De Smet, 1997 
Mucuna deeringiana Levodopa Anti-parkinsonism De Smet, 1997 
Papaver somniferum Codeine  
Morphine 
Noscapine 
Analgesic/antitussive 
Analgesic 
Antitussive 
De Smet, 1997; 
Rates, 2001 
Physostigma 
venenosum 
Physostigmine Cholinesterase 
inhibitor 
De Smet, 1997 
Pilocarpus jaborandi Pilocarpine Parasympathomimetic De Smet, 1997 
Podophyllum peltatum Podophyllotoxin Topical treatment De Smet, 1997 
Rauwolfia serpentine Reserpine Antihypertensive De Smet, 1997 
Salix capensis 
 
Catechol 
2-Hydroxybenzyl 
alcohol 
Antibacterial Masika et al., 2005 
Salvia chamelaeagnea Carnosol Antibacterial Kamatou et al., 
2007 
Terminalia sericea Anolignan Antibacterial Eldeen et al., 2006 
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The integration of medicinal plants into the mainstream healthcare system in South Africa 
presents its own challenges with the following to overcome (WHO, 2008 adapted): 
 National policy and regulation:  The prescription and use of medicinal plants is 
currently not regulated.  The result is that there is always the danger of 
misadministration, especially of toxic plants.   
 Patient safety and use:  It is believed that because herbal medicines are natural, they 
are safe.  Herbal medicines can cause harmful adverse reactions, if the medicine is of a 
poor quality, taken incorrectly or in conjunction with modern medicines.  
 Scientific evidence:  Evidence from in vivo studies to evaluate the safety and efficacy 
of traditional medicines is limited.   
 Sustainability:  Herbal medicines are collected from wild plant populations and 
cultivated from medicinal plants.  Poorly managed collections and cultivations could 
lead to the extinction of endangered plant species and destruction of natural resources. 
 Knowledge:  The use of African traditional medicine is not well documented and this 
is becoming increasing urgent due to the rapid loss of the natural habitat of some of the 
plants. 
 
Since only one-third of all diseases can be treated efficiently with currently available 
innovative drugs (Muller et al., 2000), the need for research and development of medicinal 
plants is on the increase.  Phytochemical and pharmacological studies of medicinal plants are 
essential to provide us with sound scientific data on their safety and efficacy and possibly 
provide mankind with a sound solution to the current problem of ineffective drugs. 
 
1.2 Athrixia phylicoides  
Athrixia phylicoides DC. is a well-known, multi-purpose, versatile plant and according to the 
literature, it is used as a tea and a medicine (van Wyk and Gericke, 2000).  A recent survey 
revealed that A. phylicoides is still frequently utilised as a tea and a medicine by both rural and 
urban dwellers in South Africa (Figure 1.1A) and will be purchased if commercially available 
(Rampedi and Olivier, 2005).  But despite the substantial demand for A. phylicoides, little 
scientific data on its chemical composition, toxicity and pharmacological activity has been 
published.  In contrast to the lack of scientific data available for A. phylicoides, extensive  
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B               C 
                
          D          E 
Figure 1.1: A:  Speaking to a local woman collecting A. phylicoides in Haenertsberg.  
                       B & C:  Athrixia phylicoides during the non-flowering seasons. 
                       D & E:  Athrixia phylicoides during the flowering season. 
                       [Source:  Myself (A&C), A.M. Viljoen (B&E) and G. Mbambezeli (D)] 
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research on the chemical composition, pharmacological activity and toxicity has been 
performed on another well-known and frequently consumed tea, Rooibos tea (Rabe et al, 
1994; von Gadow et al., 1997; Manzocco et al., 1998; McGaw et al., 2007; Almajano et al., 
2008; Marnewick et al., 2009). Guided by the medicinal uses (Table 1.2) and the substantial 
demand for A. phylicoides, this study encompasses a phytochemical and pharmacological 
investigation of the indigenous plant.  The biological activities investigated were based on the 
traditional uses of A. phylicoides.  Its use as a substitute for tea prompted the investigation as 
an anti-oxidant agent and the comparative anti-oxidant activity with other commercially 
available teas.  Athrixia phylicoides is also used to treat boils, sores, bad acne, infected 
wounds and cuts, and therefore its antimicrobial activity was studied.  The anti-inflammatory 
activity of the plant was investigated because of its use to treat sore feet and sore throats.  
According to the WHO, malaria has been responsible for nearly one million deaths in 2008 as 
a result of drug-resistant strains of Plasmodium falciparum (WHO, 2010).  These statistics 
prompted the investigation of A. phylicoides as an antimalarial agent.  A toxicity study was 
conducted due to the substantial use and consumption of A. phylicoides, and the lack of safety 
data for the volatile oils. 
  
1.2.1 Name derivation and common names 
The genus name Athrixia is derived from the Greek word thrix meaning hair describing the 
appearance of the leaves.  Athrixia phylicoides is commonly known as Bushman’s tea, Bush 
tea, Zulu tea (English), Boesmanstee, Bostee (Afrikaans) and Icholocholo, Itshelo, 
Umthsanelo (Zulu) (Mbambezeli, 2005). 
 
1.2.2   Description 
Athrixia belongs to the Asteraceae family which is the largest family of flowering plants 
comprising of about 1 100 genera and 20 000 species.  Nine species of the genus Athrixia 
occur in southern Africa, A. phylicoides and A. elata (wildtee) being the most common. 
Athrixia phylicoides is an erect shrub with small aromatic leaves (Figure 1.1B/C).  The upper 
surface of the leaf is dark green.  The lower surface of the leaf is covered by a mass of fine 
woolly hair giving the shrub a silvery appearance.  Athrixia phylicoides bears small purple 
flowers in late autumn (van Wyk and Gericke, 2000) (Figure 1.1D/E). 
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Table 1.2:  Traditional uses of A. phylicoides as a medicine by various ethnic groups.  
Medicinal 
use/ailments 
Ethnic group Part of plant used Literature source 
All communities Not specified Plowes and Drummond, 
1976 
Vhavenda Branches and leaves Mabogo, 1990 
Tea 
Zulu, Xhosa and 
Vhavenda 
Leaves Hutchings et al., 1996 
Sore throats  Sotho and Xhosa Leaves chewed Roberts, 1990; 
Hutchings et al., 1996 
Decoction of leaves 
for bathing sore feet. 
Watt and Breyer-
Brandwijk, 1962; 
Hutchings et al., 1996 
Sore feet Sotho 
A strong tea used as 
a soothing wash 
Roberts, 1990 
All communities Not specified Plowes and Drummond, 
1976 
Zulu Root decoctions Watt and Breyer-
Brandwijk, 1962; 
Roberts, 1990; 
Hutchings et al., 1996 
Cough remedy 
Sotho and Xhosa Leaves chewed Roberts, 1990; 
Hutchings et al., 1996 
Anti-helmintics Vhavenda Extracts from soaked 
leaves and roots 
Mabogo, 1990; 
Hutchings et al., 1996 
Aphrodisiac Vhavenda Root infusions Hutchings et al., 1996; 
van Wyk and Gericke, 
2000 
Boils, bad acne, 
infected wounds 
and cuts 
All communities Leaves Plowes and Drummond, 
1976; Roberts, 1990 
‘Blood purifier’ 
for sores and 
boils 
Zulu Plant infusion (no 
part specified) 
Hutchings et al., 1996 
Purgative Zulu Root decoctions Watt and Breyer-
Brandwijk, 1962; 
Roberts, 1990; 
Hutchings et al., 1996 
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1.2.3 Distribution 
Athrixia phylicoides grows in the eastern hilly and mountainous parts of South Africa, from 
the Eastern Cape in the south to the Soutpanberg in the Limpopo Province in the north (Figure 
1.2). 
 
                        
Figure 1.2:  Distribution of A. phylicoides in South Africa (SANBI). 
 
1.2.4 Traditional uses 
Athrixia phylicoides is a multi-purpose plant with a variety of uses such as a tea, a medicine 
and for the making of brooms (van Wyk and Gericke, 2000). The attractive plant with its small 
purple flowers and silvery leaves is very useful for decorative purposes, alone in a vase or as 
foliage in flower arrangements (Olivier and De Jager, 2005).  Athrixia phylicoides is also used 
to make baskets and is burnt as incense at ceremonies such as weddings and funerals (Olivier 
and De Jager, 2005).  The medicinal use of A. phylicoides by various ethnic groups in South 
Africa is summarised in Table 1.2. 
 
1.2.5   A review of previous studies on A. phylicoides 
Most of the literature refers to the extensive traditional use of A. phylicoides (van Wyk and 
Gericke, 2000; Olivier and De Jager, 2005; Rampedi and Olivier, 2005) and thus, it is 
remarkable that only limited research has been conducted on this indigenous plant.  This 
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implies that very little information on the chemical composition, toxicity and pharmacological 
activity of A. phylicoides is available.   
 
Phytochemical studies conducted on A. phylicoides revealed the presence of chemical 
compounds known to possess pharmacological activity, such as flavonoids (5-hydroxy-
6,7,8,3′,4′,5′-hexamethoxyflavon-3-ol; 3-O-demethyldigicitrin; 5,6,7,8,3′,4′-hexamethoxy-
flavone and quercertin) and polyphenols (Mudau et al., 2006; Mashimbye et al., 2006; 
Mavundza et al., 2010).  Further analysis revealed the absence of caffeine (CNS stimulant) 
stimulant) and pyrrolizidine alkaloids (plant toxins associated with disease in humans and 
animals) in A. phylicoides (McGaw et al., 2007).  A study on the nutrient content of A. 
phylicoides revealed the presence of approximately 13% non-structural carbohydrates, 8% 
proteins, 2.5% fatty acids, minerals (calcium, magnesium, phosphorus, potassium, sodium, 
iron, manganese, zinc, copper, aluminium, sulphur and fluoride) and traces of tannins and 
vitamins B1, B2, C and E (Olivier and Rampedi, 2008). 
 
The effect of fermentation temperature and time on the chemical composition of A. 
phylicoides was investigated by Hlahla et al. (2010).  The study revealed that neither 
fermentation temperature nor time had any significant influence on the anti-oxidant content, 
however, increasing fermentation temperature increased polyphenols and decreased tannin 
content.  In addition increasing fermentation time increased both polyphenols and tannin 
content.   
 
Few reports have been undertaken on the anti-oxidant and antimicrobial activity of A. 
phylicoides.  McGaw et al. (2007) reported that the ethanol extracts of A. phylicoides 
exhibited anti-oxidant activity comparable to that found in rooibos when using 
Trolox™equivalent anti-oxidant capacity (TEAC) assay.  It has also been reported that the 
ethanol extract of A. phylicoides displayed anti-oxidant activity in the 2,2-diphenyl-1-
picrylhydrazyl (DPPH•) free radical assay (Mavundza et al., 2007, 2010).  Mavundza et al. 
(2007) reported that the ethanol extract displayed antimicrobial activity against five micro-
organisms tested. 
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Some toxicity studies have been conducted on A. phylicoides (McGaw et al., 2007; Chellan et 
al., 2008; Mavundza et al., 2010).  Athrixia phylicoides traditional preparations (decoctions 
and infusions), aqueous and ethanol extracts were tested for toxic effects to brine shrimp 
larvae and the Vero kidney cell line.  The traditional preparations and aqueous extract had 
little effect in both assays, but the ethanol extract was toxic.  In another study, the ethanol 
extract showed low toxicity on Vero kidney cells (Mavundza et al., 2010).  Chellan et al. 
(2008) investigated the cytotoxic effect of the aqueous extract of A. phylicoides on Wistar rats 
for three months, but the extract did not cause any morbidity or mortality. 
 
Some reviews have been undertaken on A. phylicoides.  In a review conducted by Joubert et 
al. (2008), it was noted that due to its substantial use, A. phylicoides is at high risk of over-
exploitation.  The review also confirmed that very few studies have been conducted on A. 
phylicoides, and to date it is the only indigenous South African tea that has been subjected to a 
sub-chronic toxicity study.  In another review by Gulumian and Savolainen (2008), the results 
of the toxicity study conducted by Chellan et al. (2008) on A. phylicoides was discussed. 
 
1.3 Objectives of the study 
The objectives of the study were to: 
 Investigate the chemical composition of the essential oil using gas chromatography 
(GC) and gas chromatography combined with mass spectrometry (GC/MS). 
 Evaluate the antimicrobial activity of the essential oil and methanol extract on selected 
micro-organisms using the minimum inhibitory concentration method. 
 Isolate and identify the compound(s) responsible for the antimicrobial activity. 
 Investigate the anti-oxidant activity of the aqueous extract of A. phylicoides and to 
compare its activity to other commercially available teas. 
 Investigate the effect of the methanol extract and essential oil on Plasmodium 
falciparum, the protozoan responsible for malaria.   
 Investigate the anti-inflammatory activity of the methanol extract and essential oil of 
A. phylicoides. 
 Determine the toxic properties of the methanol extract and essential oil. 
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Chapter 2 – Plant collection and preparation of samples 
 
 
2.1 Collection of plant material 
A total of seven samples of A. phylicoides were collected from two natural populations over a 
period of four months from February 2004 to May 2004.  The sample populations were 
Haenertsberg in Limpopo and Dundee in KwaZulu-Natal.  Pooled samples (a number of many 
individual plants) and two individual plants were collected (Table 2.1).  Professors J. Olivier 
and A.M. Viljoen assisted with the collection of plants.  The taxonomic identification of all 
samples was confirmed by botanists at the South African National Botanical Institute (SANBI) 
in Pretoria.  Voucher specimens have been maintained at the Department of Pharmacy and 
Pharmacology at the University of Witwatersrand.  Pooled samples for both the essential oils 
and extracts have been used in the antimicrobial, anti-oxidant, antimalarial, anti-inflammatory 
and toxicity studies. 
 
Table 2.1:  Plant collection, voucher and sample reference numbers, and percentage oil yield. 
Plant 
Population 
Month of 
collection 
Type of sample Voucher 
no. 
Sample 
reference 
no. 
Yield (%) 
Haenertsberg February Pooled sample AV914 1A 0.22 
Haenertsberg February Individual AV916 1B 0.17 
Haenertsberg February Individual AV917 1C 0.18 
Haenertsberg March Pooled sample AV936 2A 0.10 
Dundee March Pooled sample AV958 2B 0.17 
Haenertsberg April Pooled sample AV977 3A 0.47 
Haenertsberg May Pooled sample AV999 4A 0.31 
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2.2 Preparation of samples 
 
2.2.1 Isolation of essential oils 
The fresh aerial parts of the plant were allowed to dry for 24 hours at room temperature.  
Conventional hydrodistillation was then carried out using a Clevenger-type apparatus for three 
hours, to selectively isolate the essential oils from the aerial parts of the plant (Figure 2.1).  
The pure essential oils were collected and the essential oil yield (Table 2.1) was recorded prior 
to storing the essential oils in amber vials at 4 °C. 
 
 
Figure 2.1:  Hydrodistillation of plant material using the Clevenger-type apparatus. 
 
2.2.2 Preparation of the solvent extracts 
Fresh aerial parts were dried at room temperature for seven days and pulverized into a fine 
powder, using a mill (Diaf R/S, sieve no. 2).  The pulverized aerial parts (5 g) were macerated 
for 24 hours with methanol (50 ml) at room temperature, than filtered through Whatman® 
No.1 filter paper (pore size:  20-25 μm). The extraction solvent was evaporated at 35 °C using 
a rotavapor (Büchi Rotavapor R-114).  The extracts were then concentrated to dryness in the 
fume-hood.  The concentrated extract was stored at 4 °C prior to analysis.  A yield of 0.04% 
was recorded for extract of sample 1A.  It is important to note that various solvent systems 
(acetone, methanol, dichloromethane, chloroform and ethanol) were assayed before methanol 
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was finally selected as the extracting solvent because this solvent extracted compounds over a 
range of polarities. 
 
2.2.3 Preparation of aqueous tea infusions 
Aqueous tea extracts were prepared by pouring boiling distilled water (250 ml) onto dry leaves 
(1.7 g), followed by stirring with a magnetic stirrer.  The leaves were brewed for 15 min.  The 
aqueous extracts were strained and filtered through Pasteur pipettes plugged with cotton wool.  
Aliquots of the filtered extracts were freeze-dried and the yield of the extracts was recorded 
(Table 2.2). 
 
Table 2.2:  Botanical name, common name and percentage aqueous extract yield. 
Botanical name Common name Yield (%) 
Aspalathus linearis Green rooibos tea 1.06 
Aspalathus linearis 
(fermented) 
Rooibos tea 1.48 
Athrixia phylicoides Bush tea (Zulu tea) 0.59 
Camellia sinesis Green tea 0.94 
Camellia sinesis 
(fermented) 
Black tea (Ceylon) 0.88 
Cyclopia intermedia Honeybush tea 1.93  
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Chapter 3 – Composition of essential oils of Athrixia phylicoides 
 
3.1 Introduction 
Essential oils are volatile, natural, complex compounds formed by aromatic plants as 
secondary metabolites.  Initially essential oils were thought to be waste products or storage 
products; however, in recent times we have begun to uncover the biological and ecological 
roles of essential oils.  Research has shown that essential oils can act as pollination agents, 
dispersal agents, defense compounds against insects and animals and as antimicrobial agents 
(Hili, 2001). 
 
Essential oils have been used for centuries in medicine.  It is believed that Arnald de Villanova 
was the first doctor to use essential oils therapeutically in the 13th century.  By the 17th century 
essential oils were widely used by pharmacists as topical preparations.  During the 19th and 
20th century much research was conducted on the nature of essential oils and aromatic 
compounds.  Physical and chemical procedures were established to analyze aromatics (Hili, 
2001).  Today essential oils are used in perfumes, make-up, sanitary products, dentistry and 
agriculture, as food preservers and additives and as natural remedies (Bakkali et al., 2008).  
The use of essential oils as natural remedies has triggered a renewed interest in essential oil 
research.  In recent years many researchers have dedicated time to establish the relationship 
between essential oils and their biological activities (Hammer et al., 1999; Hernandez et al., 
2007; van Vuuren et al., 2007). 
 
Even though the literature describes A. phylicoides as a well-known, multi-purpose, versatile 
plant, utilised as a tea and a medicine (van Wyk and Gericke, 2000), to date no data on the 
essential oil composition of this plant has been published.  This study is the first report on the 
essential oil composition of A. phylicoides. 
 
The aim of this aspect of the study was to determine the chemical composition of the essential 
oil of A. phylicoides. 
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3.2 Materials and methods 
Essential oils were distilled from the aerial parts of the plant using hydrodistillation as 
explained in Section 2.2.1 and were analysed using gas chromatography (GC) and gas 
chromatography combined with mass spectrometry (GC/MS) in collaboration with Professor 
Başer at the Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 
Eskisehir, Turkey. 
 
3.2.1 Principle of the method 
Gas chromatography is a separating technique comparing retention times of the chromatogram 
peaks with those of reference compounds run under identical conditions to identify the peaks.  
Mass spectrometry records a fragmentation pattern of a substance and provides information 
about the molecular structures.  Since the mass spectrum of a substance is unique to that 
substance, the spectrum can be compared to previously recorded spectra to identify the 
substance (Gillespie et al., 1994). 
 
3.2.2 Gas chromatography  
Analytical gas chromatography was performed using the Hewlett Packard 6890 system.  An 
HP-Innowax FSC column (60 m x 0.25 mm, 0.25 μm film thickness) was used with nitrogen 
gas as the carrier gas (1 ml/min).  The oven temperature was kept at 60 °C for 10 min and 
programmed to increase to 220 °C at a rate of 4 °C/min, then kept constant at 220 °C for 10 
min and then programmed to increase to 240 °C at a rate of 1 °C/min.  The split ratio was 
adjusted to 50:1.  The injector temperature was set at 250 °C.  The percentage amounts were 
obtained from electronic integration measurements using flame ionization detection (FID) set 
at 250 °C.  Alkanes were used as reference points in the calculation of relative retention 
indices (RRI). 
 
3.2.3 Gas chromatography combined with mass spectrometry  
Analysis of the essential oils by GC/MS was performed using a Hewlett Packard (HP) 1800A 
GCD system operating under the following conditions:  column:  HP-Innowax (60 m x 0.25 
mm, 0.25 μm film thickness); temperatures:  injection port 250 °C, column 60 °C for 10 min, 
4 °C/min to 220 °C, 220 °C for 10 min, 1 °C/min to 240 °C (total = 80 minutes).  Percentage 
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compounds were calculated from total ion chromatograms, by the computer.  To identify the 
essential oil components, the mass spectra and retention indices of the components were 
compared to the Başer, Adams and Wiley Libraries of essential oil constituents. 
 
3.3 Results and discussion 
3.3.1 Essential oil yield 
The essential oil yield among the samples studied ranged from 0.1 to 0.47% (w/w), with the 
highest essential oil yield recorded in April (0.47% w/w) and May (0.31% w/w) (Figure 3.1).  
The flowering season of A. phylicoides is late autumn (van Wyk and Gericke, 2000).  A higher 
oil yield had been recorded during the flowering months of April and May as compared to the 
non-flowering months of February and March.  Since the amount of essential oil was highest 
during the flowering months, it is possible that the plant increases the amount of oil to favour 
pollination (Palá-Pául et al., 2001).  A similar trend was observed in the leaf oil yield of 
Agathosma ovata, with values ranging from 0.23% in early spring to 0.85% in late autumn 
(flowering season) (Viljoen et al., 2006).   
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Figure 3.1:  Percentage essential oil yield for samples of A. phylicoides. 
 
In a study performed by Möller et al. (2006), it was reported that the glandular trichomes 
present on the leaf surfaces of A. phylicoides, which are believed to be responsible for 
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essential oil synthesis, bursts open during late autumn.  The time at which the trichomes bursts 
open coincided with the highest essential oil yield reported in this study.   
 
3.3.2 Essential oil composition 
The chemical compounds identified in seven samples using GC/MS analysis are reported in 
Table 3.1.  The essential oil compositions determined by GC and GC/MS revealed 182 
components representing 75.4% to 99.8% of the total oil composition.  
 
Table 3.1:  Essential oil composition of seven samples of A. phylicoides. 
RRI Compound 1A 1B 1C 2A 2B 3A 4A 
1014 Tricyclene t t t - t t t 
1032 α-Pinene 13.7 4.6 1.9 1.5 0.8 13.9 14.8 
1035 α-Thujene 0.1 t 0.1 t t 0.3 0.2 
1048 2-Methyl-3-buten-2-ol t t t t t - - 
1050 Decene t t t - - t t 
1072 α-Fenchene - - - - - t t 
1076 Camphene 0.1 - t - t 0.1 0.1 
1093 Hexanal - - - - - t t 
1100 Undecane - - t t t 5.0 2.5 
1118 β-Pinene 10.2 7.0 2.5 1.1 1.0 12.6 12.9 
1132 Sabinene 0.8 0.9 0.3 t 0.1 1.0 0.8 
1134 Thuja-2(4),10-diene t - 0.2 t 0.1 t t 
1174 Myrcene 4.1 1.5 0.2 - t 11.6 9.9 
1176 α -Phellandrene - - - t - 0.5 t 
1183 ρ-Mentha-1,7(8)-diene 
(=Pseudolimonene) 
- - - t t t t 
1195 Dehydro-1,8-cineole t t t - t t t 
1203 Limonene 1.0 0.9 1.0 1.8 0.7 4.0 3.6 
1213 1,8-Cineole 0.3 0.1 1.8 2.0 2.5 2.3 2.6 
1218 β-Phellandrene t - - t - 0.5 0.2 
1225 (Z)-3-Hexenal - - - - - t t 
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RRI Compound 1A 1B 1C 2A 2B 3A 4A 
1244 2-Pentyl furan - - - - t t t 
1246 (Z)- β -Ocimene t t - - - 1.7 0.7 
1247 6-Methyl-2-heptanone - t t t t - - 
1255 γ-Terpinene - - - - t 0.2 t 
1257 1-Dodecene t - t - t - - 
1266 (E)-β-Ocimene t - - - - 1.0 0.2 
1280 ρ-Cymene 2.8 4.0 1.4 0.9 1.0 2.1 2.5 
1290 Terpinolene - - - - - 0.1 t 
1327 (Z)-3-Hexenyl acetate 0.2 0.2 0.1 - - - - 
1348 6-Methyl-5-hepten-2-
one 
t - 0.1 0.1 t - t 
1356 1-Tridecene t - - 0.1 0.1 t t 
1382 cis-Allo-ocimene - - - - - t t 
1384 α-Pinene oxide 0.2 0.2 0.3 t 0.1 - t 
1391 (Z)-3-Hexenol t t 0.1 - - t t 
1393 3-Octanol 0.1 t 0.1 t 0.1 t t 
1400 Nonanal - 0.1 - t t - - 
1402 Tetradecane - - - t - - - 
1405 4,8-Dimethyl-1,3,7-
nonatriene 
0.3 0.3 0.4 0.1 0.1 t 0.2 
1429 Perillen 0.3 0.8 0.7 t 0.1 t 0.1 
1432 7-α-(H)-Silphiperfol-5-
ene 
t t t 0.1 0.1 t t 
1437 α-Thujone t t t t t t - 
1439 γ-Campholene aldehyde - - t - - - - 
1443 Dimethyltetradecane t t 0.1 0.7 0.1 t t 
1450 trans-Linalool oxide 
(Furanoid) 
t t 0.1 0.1 - - - 
1451 β-Thujone t 0.3 0.3 t t t t 
1452 α,ρ-Dimethylstryene - - - - - t t 
1452 1-Octen-3-ol 0.1 t t t 0.1 0.1 0.1 
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RRI Compound 1A 1B 1C 2A 2B 3A 4A 
1458 cis-1,2-Limonene 
epoxide 
- - t - t - - 
1460 7β-(H)-Silphiperfol-5-
ene 
t t - - t t t 
1466 α-Cubebene t t 0.1 0.1 0.1 0.1 0.1 
1475 Menthone - t - - - - - 
1477 4,8-Epoxyterpinolene - t - - - - - 
1478 cis-Linalool oxide 
(Furanoid) 
t t 0.1 0.1 0.1 t t 
1481 Longipinene t -  - - - - - 
1493 α-Ylangene 0.1 0.1 0.1 t t 0.1 0.1 
1495 Bicycloelemene - - - - - t t 
1496 3-Nonanol t - - - - - - 
1497 α-Copaene 0.4 0.2 0.6 t 0.3 0.5 0.4 
1499 α-Campholene aldehyde t - - 0.2 - - - 
1503 Isomenthone - t - - - - - 
1507 (E,E)-2,4-Heptadienal - - - - - 0.1 t 
1528 α-Bourbonene t t t t t t t 
1532 Camphor - - t t - - - 
1535 β-Boubonene 0.1 0.1 0.2 0.2 t 0.1 0.2 
1544 α-Gurjunene t t - - t t t 
1549 β-Cubebene - t - t - 0.1 - 
1553 Linalool 1.3 0.5 1.7 0.1 2.4 1.1 1.0 
1556 cis-Sabinene hydrate - - - - 0.1 - - 
1557 1-Nonen-3-ol t 0.1 0.1 - - - t 
1559 8,9-Limonene epoxide I - - - - t - - 
1562 Octanol - - - t - - - 
1571 trans-ρ-Menth-2-en-1-ol t 0.1 0.1 t t t t 
1574 8,9- Limonene epoxide 
II 
- - t - t - - 
1586 Pinocarvone 0.3 0.2 0.7 0.2 0.3 0.1 0.2 
1589 β-Ylangene 0.1 t 1.3 0.1 0.3 0.3 0.2 
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RRI Compound 1A 1B 1C 2A 2B 3A 4A 
1592 Nopinone - t 0.6 0.1 0.1 - - 
1594 trans-β-Bergamotene - 0.2 - t t 0.5 0.1 
1600 β-Elemene 0.6 2.4 0.3 1.1 0.1 0.3 t 
1602 β-Copaene - t 0.1 0.3 0.1 0.1 t 
1604 6-Methyl-3,5-heptadien-
2-one 
- t - - - - - 
1611 Terpinen-4-ol 0.2 2.7 0.2 0.2 0.1 0.4 0.5 
1612 β-Caryophyllene 8.3 5.4 0.3 0.2 2.2 11.9 10.0 
1628 Aromadendrene 0.1 0.1 t 0.4 0.1 - t 
1638 cis-ρ-Menth-2-en-1-ol - 0.1 - - - t t 
1639 trans-ρ-Mentha-2,8-
dien-1-ol 
- - t t 0.1 - - 
1648 Myrtenal 0.6 0.7 1.7 0.3 0.8 0.1 0.3 
1661 Alloaromadendrene 0.3 0.2 0.2 0.2 0.1 0.2 0.2 
1668 (Z)-β-Farnesene - - - - - 0.1 0.1 
1670 trans-Pinocarveol 0.7 0.9 2.4 0.4 1.4 0.1 0.4 
1677 epi-Zonarene - - - - - t 0.1 
1678 cis-ρ-Mentha-2,8-dien-
1-ol 
- - - t 0.1 - - 
1683 trans-Verbenol - 0.1 1.4 0.3 t t 0.3 
1687 α-Humulene 0.9 0.1 - - 1.2 0.4 0.5 
1688 Selina-4,11-diene 
(=4,11- Eudesmadiene) 
- - - 0.1 0.1 0.1 t 
1695 (E)- β-Farnesene - 0.1 - t t 0.1 0.1 
1700 ρ-Mentha-1,8-dien-4-ol 
(=Limonen-4-ol) 
- - - 0.1 t - - 
1704 γ-Muurolene 0.5 0.8 0.6 1.0 0.5 0.2 1.1 
1706 α-Terpineol - t t t t - - 
1708 Ledene - t - - t t 0.1 
1719 Borneol t t t 0.1 0.1 t t 
1720 trans-Sabinol t - - - - 0.1 t 
1725 Verbenone 0.3 0.1 0.8 0.2 0.4 - t 
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RRI Compound 1A 1B 1C 2A 2B 3A 4A 
1726 Germacrene D 2.7 0.1 - - t 13.5 5.5 
1740 α-Muurolene 0.7 0.4 0.7 0.7 0.8 0.4 0.7 
1741 Valencene 0.1 t t t t - - 
1742 β-Selinene 0.1 - t 0.7 t 0.1 0.2 
1751 Carvone - - 0.1 0.2 0.2 - - 
1755 Bicyclogermacrene 0.2 0.1 t - - 2.4 0.4 
1758 (E,E)-α-Franesene t - - - - 0.2 0.1 
1760 1-Heptadecene t - - - - - - 
1764 cis-Chrysanthenol - 0.1 0.1 - 0.3 - - 
1773 δ-Cadinene 0.4 t t t t 0.9 1.0 
1776 γ-Cadinene 0.6 0.6 0.3 0.6 0.1 0.3 0.6 
1783 β-Sesquiphellandrene - - - - - t t 
1784 (E)-α-Bisabolene t - - - - t t 
1797 ρ-Methyl acetophenone - - 0.1 t 0.1 - - 
1804 Myrtenol 0.4 0.6 1.6 0.4 0.9 0.1 0.3 
1807 α-Cadinene  0.1 t - - 0.1 0.1 0.1 
1845 trans-Carveol 0.1 t 0.4 0.2 0.3 t 0.1 
1853 cis-Calamenene 0.2 0.3 0.1 0.1 0.1 0.1 0.3 
1857 Geraniol - 0.1 t - - 0.1 t 
1864 ρ -Cymen-8-ol 0.1 0.4 0.2 0.1 t t 0.1 
1868 (E)-Geranyl acetone t t t 0.2 0.2 t 0.1 
1882 cis-Carveol - - 0.1 0.1 0.2 t t 
1900 epi-Cubebol 0.3 t 0.2 0.2 0.2 0.2 0.2 
1937 α-Calacorene I - 0.3 0.1 0.1 0.1 0.1 t 
1945 1,5-Epoxy-salvial(4)14-
ene 
0.2 0.5 1.3 1.5 1.1 t 0.3 
1949 (Z)-3-Hexenyl 
nonanoate 
t t 0.2 t t - t 
1953 Palustrol - 0.2 0.2 t t t t 
1957 Cubebol t 0.2 - 0.2 0.3 0.2 0.2 
1984 γ-Calacorene  0.1 0.1 0.2 t 0.2 t - 
2001 Isocaryophyllene oxide 1.4 1.3 4.0 0.7 4.0 0.1 0.7 
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RRI Compound 1A 1B 1C 2A 2B 3A 4A 
2008 Caryophyllene oxide  6.2 21.2 21.4 34.2 18.5 1.0 4.1 
2033 Epiglobulol - - - 0.1 0.1 - - 
2037 Salvial-4(14)-en-1-one 0.2 0.4 0.1 0.2 0.2 t 0.2 
2041 Pentadecanal 0.1 - - 0.2 - t t 
2050 (E)-Nerolidol - - t - - t t 
2057 Ledol 0.2 0.2 0.2 0.3 0.1 0.1 0.1 
2071 Humulene epoxide-II 0.2 0.2 0.9 0.9 0.7 t 0.1 
2080 1,10-di-epi-Cubenol 0.2 0.3 0.1 0.1 t 0.1 0.2 
2088 1-epi-Cubenol 0.7 0.2 0.4 0.3 0.6 0.3 0.5 
2098 Globulol 0.2 0.1 - 1.2 0.6 0.2 0.3 
2104 Viridiflorol 0.2 0.1 0.1 0.4 0.3 0.1 0.1 
2113 Cumin alcohol - - t 0.1 t - - 
2131 Hexahydrofarnesyl 
acetone 
- t 0.3 - t t 0.1 
2144 Rosifoliol 0.1 0.1 t t 0.1 t 0.1 
2151 Salviadienol 0.4 0.3 0.3 0.1 0.1 t 0.2 
2164 Spathulenol 4.1 8.5 2.7 9.9 12.6 1.5 3.4 
2169 6-epi-Cubenol 0.1 0.4 0.1 0.2 - 0.1 0.2 
2179 Nor-Copaonone - t 0.1 - - - - 
2187 T-Cadinol 0.7 1.0 0.5 0.3 0.3 0.3 0.6 
2209 T-Muurolol 0.6 0.9 0.5 0.4 0.3 0.3 0.6 
2214 Torreyol 0.4 0.3 0.3 0.3 0.2 0.3 0.3 
2219 Dimyrcene II-a - 0.1 0.1 - - 0.3 0.1 
2228 Isospathulenol 0.1 t - 0.2 0.2 - - 
2247 trans-α-Bergamotol 0.4 0.1 0.1 0.1 0.4 0.2 0.3 
2249 Torilenol 1.0 2.2 0.8 0.2 0.3 t 0.3 
2255 α-Cadinol 1.1 2.0 1.3 1.1 0.9 0.5 1.0 
2268 4,7-Dimethyl-1-tetralone - 0.1 0.3 0.1 - - - 
2269 Dimyrcene II-b - 0.3 - - - 0.1 0.1 
2273 Selin-11-en-4α-ol 0.1 0.1 0.1 0.7 0.1 - - 
2287 4-Oxo-α-ylangene (= 
Mustakone) 
- t 0.3 0.5 0.3 - - 
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RRI Compound 1A 1B 1C 2A 2B 3A 4A 
2315 Eudesma-4(5),7-dienol 
isomer¥ 
1.1 0.8 0.4 0.1 0.2 0.3 0.6 
2316 9-Geranyl-ρ-cymene t t t - t t t 
2320 Caryophylla-
2(12),6(13)-dien-β-ol 
(=Caryophylladienol I) 
0.2 0.2 0.5 0.3 0.5 0.1 0.2 
2323 14-nor-Cadin-5-en-4-
one* 
0.3 0.2 0.6 0.5 1.0 - - 
2389 Caryophylla-2(12),6-
dien-5α-ol 
(=Caryophyllenol I) 
0.1 0.1 0.1 0.4 0.3 0.1 0.1 
2395 cis-Calamenenol¥ 0.2 0.1 0.1 t t t t 
2415 Eudesma-4(5),7-dien-
1β-ol 
0.9 0.9 1.0 t 0.6 0.2 0.4 
2425 trans-Calamenenol¥ 0.4 0.3 0.5 0.8 1.3 t 0.1 
2427 Farnesyl acetone - t - - 0.1 t t 
2433 Caryophylla-2(12),6-
dien-5β-ol 
(=Caryophyllenol II) 
0.4 0.5 1.4 2.0 0.2 0.1 0.2 
2489 Demethoxyencecaline - - t - - t t 
2500 Pentacosane - - t - 0.2 - - 
2552 Oplopanone - 0.5 0.6 - - - - 
2554 Geranyl linalool 0.2 0.1 0.6 - 0.2 0.2 0.6 
2570 14-Hydroxy-α-
muurolene 
0.1 0.2 0.1 t - t t 
2575 ent-4β,10α-Dihydroxy-
aromadendrane¥ 
0.1 t 0.3 0.4 1.5 t 0.1 
2651 ent-4β,10α-Dihydroxy-
aromadendrane isomer¥ 
- - t 0.4 0.6 t - 
2622 Phytol - - - - 0.2 0.1 0.1 
2700 Heptacosane - - - - 0.3 - - 
2816 Unknown† 0.9 1.5 2.0 1.1 3.3 0.3 1.1 
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RRI Compound 1A 1B 1C 2A 2B 3A 4A 
2908 Unknown†† 2.0 1.1 1.0 3.6 2.1 0.1 0.6 
2931 Hexadecanoic acid 0.2 t t t t t t 
 Total 81.2 87.0 75.4 82.1 76.8 99.8 95.3 
  RRI  Relative retention indices calculated against n-alkanes; 
  t Trace (< 0.1%);   % calculated from FID data;  
  * Correct isomer not characterized; 
    ¥ Tentatively identified from Wiley, Adams, NIST libraries; 
   † Mass spectrum of unknown constituent: EIMS, 70 eV, m/z (rel. int.): 107(100), 121(82), 81(76), 93(71),   
  43(64), 159(63), 55(58), 177(54), 220(44), 69(41), 189(24), 202(22). 
   †† Mass spectrum of unknown constituent: EIMS, 70 eV, m/z (rel. int.): 193(100), 91(92), 123(86), 107(82),   
  133(75), 81(69), 41(61), 55(60), 175(54), 147(52), 236(48), 69(38), 153(26), 218(17). 
  Bold text represents major compounds. 
 
 
 
Major compounds:  Major compounds (>10%) identified in the volatile oil of A. phylicoides 
studied were α-pinene, β-pinene, myrcene, germacrene D, β-caryophyllene, spathulenol and 
caryophyllene oxide (Figure 3.2). 
                                                                                                            
           α-pinene                                         β-pinene                                     myrcene 
                                 
            germacrene D                                                                β-caryophyllene 
 
H
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             spathulenol                                                              caryophyllene oxide 
 
Figure 3.2:  Chemical structures for major compounds identified in the essential oil of A. 
phylicoides. 
 
Essential oils are known to exhibit various pharmacological activities, however the 
constituents responsible for these activities remain largely unidentified (van Zyl et al., 2006).  
Some of the major essential oil constituents present in A. phylicoides are known to possess 
pharmacological activities.  Essential oil constituents, β-caryophyllene (10 ≤ IC50 ≤ 30 ppm); 
germacrene D (10 ≤ IC50 ≤ 30 ppm) and α-pinene (31 ≤ IC50 ≤ 50 ppm) exhibited anti-
inflammatory activity against the 5-lipoxygenase enzyme (Baylac and Racine, 2003).  In a 
study conducted by van Zyl et al. (2006), it was reported that α-pinene displayed potent 
antimalarial activity against the chloroquine- resistant strain of P. falciparum (FRC-3) (IC50 = 
1.2 ± 0.2 μM).  The toxicity of some of the major essential oil constituents of A. phylicoides 
have also been investigated.  Caryophyllene oxide has been reported to have cytotoxic activity 
(IC50 values range from 147 to 351 μM) against human tumour cells (Sibanda et al., 2004).  In 
another study, it has been reported that α-pinene (IC50 = 172.2 ± 13.4 μM) and β-pinene (IC50 
= 166.7 ± 19.6 μM) displayed some degree of toxicity against human kidney epithelial cells 
(van Zyl et al., 2006). 
 
Quantitative variation in major compounds of the essential oil in the seven samples studied has 
been observed (Figure 3.3).  No specific trend was noticed for the major compounds, however 
remarkable fluctuations in quantities included caryophyllene oxide (1.0% to 34.2%), β-pinene 
(1.0% to 12.9%), α-pinene (0.8% to 14.8%), spathulenol (1.5% to 12.6%), germacrene D (0% 
to 13.5%), β-caryophyllene (0.2% to 11.9%) and mycrene (0% to 11.6%).  The most 
H 
H 
OH
R 
O 
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conspicuous variation in major compounds was noted for caryophyllene oxide, ranging from 
1.0% to 34.2%.  α-Pinene was found to be the main constituent of samples 1A/Feb (13.7%), 
3A/Apr (13.9%) and 4A/May (14.8%) and caryophyllene oxide was the main constituent of 
samples 1B/Feb (21.2%), 1C/Feb (21.4%), 2A/Mar (34.2%) and 2B/Mar (18.5%). Spathulenol 
(12.6%) was identified as a major compound in sample 2B/Mar only.  It was also noted that 
the essential oil compositions of samples 3A/Apr and 4A/May were similar (Figure 3.3).  The 
major compounds represented between 21.2% and 63.5% of the total oil composition (Table 
3.1). 
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Figure 3.3:  Major compounds identified in A. phylicoides.  
 
 
The results from this study revealed that variation in essential oil composition exists in the 
same species (A. phylicoides) collected from the same location.  The composition of the 
essential oils can be affected by many factors such as development or reproductive stages, 
seasons, location, temperature, extraction method and the conditions of analysis (Putievsky et 
al., 1986; Sangwan et al., 2001; Kim and Lee, 2004).  In a study by Simmons et al. (1987), it 
was reported that the variation in essential oil composition of Eucalyptus ovata and 
Eucalyptus camphora could be attributed to the leaf ageing effect.  Kamatou et al. (2008) 
reported seasonal variation in essential oil composition for three South African Salvia species.  
The composition of the essential oil of sage has been found to change under the influence of 
temperature (Avato et al., 2005).  The variation in essential oil composition noted in this study 
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may be as a result of various factors, such as temperature, age of the leaves, development 
stages and genetic factors. 
 
In a study conducted on Athrixia elata, the following constituents were found in the aerial 
parts:  squalene, germacrene D, caryophyllene, α-humulene and cinnamates (Bohlmann et al., 
1982).  Some of the constituents found in A. elata are also present in A. phylicoides in varying 
quantities:  germacrene D – trace to 13.5%; caryophyllene – 0.2 to 11.9% and α-humulene – 
0.1 to 1.2%. 
 
3.4 Conclusions 
 A higher percentage essential oil yield was recorded for A. phylicoides collected during 
the flowering months of April and May (0.47% and 0.31%) compared to the non-
flowering months (0.1% to 0.2%). 
 Seven major compounds (>10%) were identified in the samples of A. phylicoides 
studied: caryophyllene oxide, spathulenol, germacrene D, β-caryophyllene, β-pinene, 
α-pinene and myrcene. 
 Variation in the essential oil composition of A. phylicoides from within the same 
population and between populations has been noted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 27
Chapter 4 – Antimicrobial activity and isolation of bioactive   
                     compound 
 
 
4.1 Introduction 
The discovery of antimicrobial agents during the twentieth century substantially reduced the 
threat posed by infectious diseases.  Antimicrobial agents combined with improvements in 
sanitation, housing and nutrition, and the advent of widespread immunization programmes, 
ensured a dramatic drop in deaths from diseases that were previously widespread, untreatable 
and frequently fatal.  Over the years, antimicrobial agents have saved lives, eased the suffering 
of millions of people and contributed to increasing life expectancy (WHO, 2002). 
 
This significant advancement in medicine is now under severe threat by another recent 
development, the emergence and spread of micro-organisms that are resistant to antimicrobial 
agents (WHO, 2002).  The consequences of resistant micro-organisms are severe.  Infections 
caused by resistant micro-organisms do not respond to treatment with antimicrobial agents, for 
example nosocomial infections caused by methicillin resistant Staphylococcus aureus will not 
respond to methicillin and community acquired pneumonia caused by strains resistant to 
penicillin will not respond to penicillin and even sometimes cephalosporins.  The result is 
prolonged illness, increasing the risk of death.  In addition, the prolonged illness leads to 
longer periods of infectivity, which can increase the number of infected people moving in the 
community and thus expose the general population to the risk of contracting a resistant strain 
of the infection (WHO, 2002).  With the continuous escalation of antimicrobial resistance, the 
acceptance of traditional medicine as an alternative form of health care by South Africans has 
increased.  For this reason, medicinal plants have become the focus of intense study to 
determine whether their traditional uses can be supported by pharmacological effects or are 
merely based on folklore (Rabe and van Staden, 1997).   
 
A survey of the literature revealed that the leaves of A. phylicoides have been used for the 
treatment of boils, sores, bad acne, infected wounds and cuts (Table 1.2) (Plowes and 
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Drummond, 1976; Roberts, 1990; Hutchings et al., 1996).  This information prompted an 
investigation into the in vitro antimicrobial activity of A. phylicoides. 
 
The aims of this study were to: 
 investigate the essential oil and methanol extract of the indigenous plant A. 
phylicoides for potential antimicrobial activity. 
 isolate and identify the compound/s exhibiting antimicrobial activity. 
 
4.2 Materials and methods 
 
4.2.1 Minimum inhibitory concentration assay 
The anitmicrobial activity of the essential oil and methanol extract of A. phylicoides was 
assessed using the minimum inhibitory concentration microdilution (MIC) assay (Eloff, 1998).  
 
4.2.1.1 Principle of the method 
The minimum inhibitory concentration (MIC) is the lowest concentration at which the growth 
of the bacteria is inhibited.  The ρ-iodonitrotetrazolium (INT) microplate bioassay technique 
was used to determine the MIC (Eloff, 1998).  Microbial growth is indicated by the presence 
of a reddish colour, which is produced when INT (colourless product) is reduced by 
metabolically active micro-organisms to the corresponding intensely coloured formazan.  
Therefore the MIC value is the concentration of the first well in which no colour change is 
observed (Figure 4.1). 
 
4.2.1.2 Protocol 
Five Gram-positive bacteria:  Staphylococcus aureus (ATCC 12600), Enterococcus faecalis 
(ATCC 29212), Bacillus cereus (ATCC 11778), Staphylococcus epidermidis (ATCC 2223) 
and Bacillus subtilis (ATCC 6051); four Gram-negative bacteria: Klebsiella pneumoniae 
(NCTC 9633), Escherichia coli (ATCC 8739), Yersinia entercolitica (ATCC 23715) and  
Salmonella typhimurium (ATCC 14028) and two yeasts: Candida albicans (ATCC 10231) and 
Candida tropicalis (ATCC 750) were used to evaluate the antimicrobial activity of the 
essential oil and methanol extract of A. phylicoides.   
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Figure 4.1:  Microtitre plate for Salmonella typhimurium where column 1 is the essential oil 
(concentrations decreasing from 32 mg/ml in row A to 0.25 mg/ml in row H), column 2 is the 
extract (concentrations decreasing from 16 mg/ml in row A to 0.125 mg/ml in row H), column 
3 is a positive control and column 4 is a negative control. 
 
The test solutions were prepared by diluting the essential oil and methanol extract in acetone 
to achieve a final concentration of 128 mg/ml and 64 mg/ml, respectively.  The inoculum was 
prepared by mixing 1 ml of the respective bacteria and yeast grown overnight with 99 ml of 
fresh Tryptone Soya broth.  INT was prepared by dissolving 40 mg in 100 ml sterile water.  
 
For each micro-organism, columns in the microtitre plate were reserved for positive and 
negative controls.  Commercial antimicrobials (ciprofloxacin and amphothericin B) were used 
as positive controls for the bacteria and yeast, respectively.  Ciprofloxacin (1 mg/ml) and 
amphothericin B (1 mg/ml) was diluted (1:10) with sterile water and DMSO, respectively to 
achieve a concentration of 0.01 mg/ml.  For negative controls, wells containing acetone (100 
μl) and no plant extract were prepared for the observation of normal bacterial and fungal 
growth.  In the microtitre plate, 100 μl sterile water was added to each well.  The test solution  
(100 μl) was added to each well in row A of the plate.  Serial dilutions (1:1) were made in the  
 
Red well – 
bacterial growth 
Clear well – inhibition of 
bacterial growth.   
MIC - 8 mg/ml and  
4 mg/ml, respectively 
Serial dilution (1:1) 
ROW A
ROW H
    1     2      3      4 1 2 3 4
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microtitre plates.  Inoculum (100 μl), yielding an inoculum size of 1 x 106 CFU/ml was then 
added to each well to achieve final concentrations of 32 mg/ml in row A to 0.25 mg/ml in row 
H for the essential oil and 16 mg/ml in row A to 0.125 mg/ml in row H for the extract, 
respectively.  The plates were incubated at 37 °C for 24 hours for bacteria and 48 hours for 
yeast.  After incubation, 50 μl INT (0.04% w/v) was added to each well and the plates were 
left at room temperature for six hours for bacteria and 24 hours for yeast before MIC’s were 
determined visually.  All organisms were tested in duplicate (two columns each) for the 
essential oil and the methanol extract (Figure 4.1).  The minimum inhibitory assays were 
repeated and the mean was calculated. 
         
4.2.2 Isolation of the bioactive compound  
The methanol extract of A. phylicoides was selected to isolate the bioactive compound/s, since 
it displayed favourable antimicrobial activity. 
 
4.2.2.1 Column chromatography 
Column chromatography was conducted to isolate the compound/s responsible for 
antimicrobial activity (Figure 4.2).  Silica mixed with hexane and ethyl acetate was poured 
into the column and allowed to settle for a few minutes.  The plant extract dissolved in ethyl 
acetate was carefully pipetted along the rim of the column.  The column was eluted 
successively with hexane:ethyl acetate (6:4), then hexane:ethyl acetate (7:3) followed by  
100% ethyl acetate and finally stripped with 100% methanol.  The collection of these crude 
fractions was based on colour change.  The fractions were collected in 250 ml conical flasks 
and spotted on TLC plates.  TLC plates were developed in hexane:ethyl acetate (6:4).  
Fractions displaying similar chromatographic profiles on the TLC plates were combined to 
yield four main fractions (A-D). 
 
4.2.2.2 Thin layer chromatography and bio-autographic assay 
A direct antimicrobial bioassay on a thin layer chromatography plate was employed using the 
agar-overlay method with Staphylococcus aureus (ATCC 12600) as the test organism to 
isolate the bioactive compound.  S. aureus was chosen as the test organism because it is one  
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Figure 4.2:  Preparing a silica column for column chromatography used to separate fractions.  
 
of the most difficult bacterial strains to treat with conventional antibiotics (Esposito et al., 
2009).  Each of the four fractions were spotted on a TLC plate (Alugram® Sil G/UV254, 0.200 
mm) and developed in a hexane:ethyl acetate (6:4) solvent system.  The TLC plate was then 
dried and sterilised under UV light (254 mm) for one hour.  Tryptone Soya agar (15 ml) was 
poured into a petri dish and allowed to solidify.  The sterilised TLC plate was placed onto the 
agar surface with the silica side facing upwards.  An overlayed layer of Tryptone Soya agar 
(15 ml) containing 150 μl of S. aureus (approximate inoculum size, 1 x 106 CFU/ml)) was 
placed on top of the TLC plate.  The petri-dish was placed in the refrigerator (4 °C) for one 
hour to allow the compounds on the TLC plate to diffuse into the agar.  The plate was then 
removed and incubated at 37 °C for 24 hours.  At the end of the incubation period, the TLC 
plate was sprayed with INT (0.04% w/v) to visualise the inhibition zone.  The inhibition zone 
was indicated by the clear zone on the red background (Figure 4.3).  On evaluation of the bio-
autographic assay of the four fractions, the best zone of inhibition was observed around 
Fraction D and was thus selected for further purification (Figure 4.3). 
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Figure 4.3:  Bio-autographic assay of A. phylicoides against the test pathogen S. aureus.  
(Inhibition zones are shown by clear spots on the red background.)  
 
4.2.2.3 Bioactivity-guided fractionation and isolation 
Column chromatography yielded four fractions of which Fraction D was the most bioactive 
(Figure 4.3).  A second column was prepared in order to fractionate Fraction D.  A total of 57 
sub-fractions were collected and spotted on TLC plates. The bioactivity-guided fractionation 
procedure is summarized in Figure 4.4. 
 
4.2.2.4 Identification, elucidation and minimum inhibitory concentration of the isolated 
compound 
 
4.2.2.4.1 Nuclear magnetic resonance  
The isolated compound was structurally characterized using nuclear magnetic resonance 
(NMR) and MS and data compared to those found in the literature in collaboration with 
Professor F.R. van Heerden at the University of KwaZulu-Natal.  Spectra were recorded on a 
Varian Inova 2000 300 MHz spectrometer.  All spectra were recorded at 25 ˚C in denatured 
chloroform and the chemical shifts were recorded in ppm referenced to tetramethylsilane.  
Electron ionization MS of the isolated compounds was performed by direct inlet at 70 eV on 
the GC-MS QP 2010 GC coupled to MS. 
 
Crude 
extract 
Fraction D – 
bioactive fraction 
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Crude A. phylicoides methanol extract  
13.57 g 
                                                                                        Silica gel 60 
                                                                                                Hexane:ethyl acetate (6:4) 
                                                                                                Hexane:ethyl acetate (7:3) 
                                                                                               Ethyl acetate 100%                                                                 
                                                                                                Methanol 100% 
 
340 fractions 
 
                  
Fraction A  Fraction B       Fraction C          Fraction D 
(13-25)  (45-51)       (61-87)         (91-102) 
70 mg   37.7 mg       48.9 mg         41.5 mg 
                                                                                                        
                                                                                                   57 fractions 
                                                                                      Sephadex LH-20 
                                                                                             Methanol 100% 
                                                                                             Chloroform 
                                                                                    
                                                                        Subfractions 16-18  
                                                                                21.5 mg 
 
 
 
 
Figure 4.4:  Bioactivity-guided fractionation procedure (All fractions and sub-fractions not 
listed had low activity and were not considered for further purification).                                                            
 
 
 
 
Antimicrobial 
compound 
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4.2.2.4.2 Antimicrobial activity of the isolated compound 
The antimicrobial activity of the isolated compound of A. phylicoides was assessed using the 
MIC assay as described in Section 4.2.1.  Three micro-organisms were chosen for the MIC 
assay, i.e. one Gram-positive bacterium:  Staphylococcus aureus (ATCC 12600); one Gram-
negative bacterium:  Escherichia coli (ATCC 8739) and one yeast Candida albicans (ATCC 
10231).  Only three micro-organisms could be used in the MIC assay because of a limited 
quantity of isolated compound.  Commercial antimicrobials (ciprofloxacin and amphothericin 
B) were used as positive controls for the bacteria and yeast, respectively.   
 
4.3 Results and discussion 
4.3.1 Antimicrobial activity:  Extract, essential oil and bioactive compound 
The MIC assay revealed that both the extract and essential oil were active against some of the 
test organisms (Table 4.1).  The methanol extract displayed stronger antimicrobial activity 
towards all test organisms than the essential oil.  The average MIC values obtained for the 
extract against each organism ranged from 1 to 6 mg/ml; while the average MIC values 
obtained for the essential oil against each organism ranged from 3 to >32 mg/ml.  It has been 
reported that an essential oil with a MIC ≤2 mg/ml, an extract with a MIC <8 mg/ml and a 
bioactive compound with a MIC value ranging between 64 – 100 μg/ml  are considered to 
possess noteworthy antimicrobial activity (Fabry et al., 1998; Gibbons, 2004; van Vuuren, 
2008).  The highest sensitivities for the methanol extract were against S. aureus, B. cereus and 
B. subtilis (MIC value: 1 mg/ml) and the essential oil was moderately active against B. cereus 
(MIC value:  3 mg/ml).   
 
The MIC assay revealed that A. phylicoides bioactive compound displayed antimicrobial 
activity and was most active against the Gram-positive bacterium, S. aureus (MIC value:  19.5 
µg/ml).  The bioactive compound also displayed some antimicrobial activity against the Gram- 
negative bacterium, E. coli and the yeast, C. albicans.   
 
The bioactive compound was 51 times more active compared to the methanol extract against 
S. aureus, 26 times more active compared to the methanol extract against C. albicans and 24 
times more active compared to the methanol extract against E. coli. 
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Table 4.1:  Antimicrobial activity of A. phylicoides methanol extract, essential oil and 
bioactive compound (n = 2). 
Test Organism Essential Oil 
(mg/ml) 
Extract  
(mg/ml) 
Bioactive 
compound 
(µg/ml) 
Control 
(µg/ml) 
Bacillus cereus 
(ATCC 11778) 
3 1 ND 0.6 
(a) 
Bacillus subtilis 
(ATCC 6051) 
6 1 ND 0.3 
(a) 
Enterococcus faecalis 
(ATCC 292192) 
> 32 4 ND 0.3 
(a) 
Staphylococcus aureus 
(ATCC 12600) 
24 1 19.5 0.6 
(a) 
Staphylococcus 
epidermidis 
(ATCC 2223) 
24 3 ND 0.6 
(a) 
Escherichia coli 
(ATCC 8739) 
12 3 125 0.15 
(a) 
Klebsiella pneumoniae 
(NCTC 9633) 
12 6 ND 0.3 
(a) 
Salmonella 
typhimurium 
(ATCC 14028) 
> 32 6 ND 0.6 
(a) 
Yersenia entercolitica 
(ATCC 23715) 
12 3 ND 0.3 
(a) 
Candida albicans 
(ATCC 10231) 
6 2 78 0.15 
(b) 
Candida tropicalis 
(ATCC 750) 
4 1.5 ND 0.15 
(b) 
     (a) Ciprofloxacin 
     (b) Amphothercin B 
     ND – Not determined 
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The plant extract, the bioactive compound and the essential oil displayed better activity against 
the Gram-positive bacteria than the Gram-negative bacteria.  These results are consistent with 
results from previous in vitro studies with plant extracts and essential oils (Hernandez et al., 
2007; Nyiligira et al., 2008; Mahboubi and Haghi, 2008; Paraskeva et al., 2008; Lalli et al., 
2008). It is believed that the difference in structure, that is, the hydrophobic 
lipopolysaccharide in the outer membrane of Gram-negative bacteria provides an additional 
barrier to agents making them more resistant to the inhibitory effects of agents compared to 
Gram-positive bacteria (Delaquis et al., 2002; Mahboubi and Haghi, 2008). 
 
In a study conducted by Mavundza et al. (2007), the antimicrobial activity of the ethanol 
extract of A. phylicoides (collected from Venda in the Limpopo Province, South Africa in mid-
July) was investigated.  The micro-organisms tested were S. aureus (ATCC 12600), B. cereus 
(ATCC 11778), E. faecalis (ATCC 292192), E. coli (ATCC 11775) and Mycobacterium 
smegmatis (ATCC X).  The extract displayed inhibitory activity against all micro-organisms 
tested.  These results are congruent with the results obtained in this study, in which the 
methanol extract also displayed inhibitory activity against S. aureus, B. cereus, E. faecalis and 
E. coli (Table 4.1).   
 
Athrixia phylicoides plant extract had MIC values below 8 mg/ml for all organisms tested 
(Table 4.1) and the bioactive compound had MIC values of 19.5 μg/ml and 78 μg/ml for S. 
aureus (Gram-positive bacteria) and C. albicans (yeast) respectively.  As such it can be 
concluded that A. phylicoides plant extract possesses some antimicrobial activity (Fabry et al., 
1998; Gibbons, 2004).  Furthermore the antimicrobial activities exhibited by the crude plant 
extract and the bioactive compound of A. phylicoides against S. aureus (MIC values: 1 mg/ml 
and 19.5 μg/ml) must be emphasised.  Infections caused by S. aureus are difficult to treat 
because often it does not respond to conventional antibiotic therapy, which can result in high 
morbidity and substantial costs (Esposito et al., 2009).  In addition, S. aureus has been 
recognised as a significant cause of nosocomial infections (Esposito et al., 2009).  This 
noteworthy antimicrobial activity of A. phylicoides extract and bioactive compound against S. 
aureus (Table 4.1) can therefore pave the way for further in vitro and possibly in vivo tests to 
yield compounds that can improve the treatment of infections caused by S. aureus.  The in 
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vitro antimicrobial activity of A. phylicoides obtained from this study, justifies its use as a 
traditional remedy to treat boils, sores, bad acne, infected wounds and cuts (Table1.2).      
 
4.3.2 Bioactivity-guided fractionation and isolation 
Two active substances were visible on the TLC plate (Figure 4.3) for Fraction D, whereas only 
one active substance was visible for the crude extract.  However following the TLC of 
fractions of the second column which separated the constituents of Fraction D, only active 
substance was visible for both the fractions and the crude extract.  It can therefore be 
concluded that the second compound for Fraction D was probably due to degradation during 
isolation or due to concentration effects.  Only one active compound was present in the A. 
phylicoides methanol extract. 
 
4.3.3 Elucidation and identification of the isolated compound 
Based on the1H-NMR, 13C-NMR, DEPT, COSY spectra and comparison with data obtained in 
the literature, the compound was identified as (4-hydroxyphenyl)propyl coumaroate (Figure 
4.5).  The chemical shift data (Table A.1) as well as the 13C and 1H spectra (Figures A.1 and 
A.2) for (4-hydroxyphenyl)propyl coumaroate has been included in Appendix A.  
(4-Hydroxyphenyl)propyl coumaroate has been previously identified in A. elata, however, no 
data has been published on any of the biological activities of the compound (Bohlmann and 
Zdero, 1977; Bohlmann et al., 1982).  (4-Hydroxyphenyl)propyl coumaroate is an ester of 
coumaric acid. 
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Figure 4.5: Structure of (4-hydroxyphenyl)propyl coumaroate isolated from A. phylicoides. 
 
 38
Coumarins are found in many families of plants such as Apiaceae, Asteraceae, Leguminoseae, 
Rosaceae, Rubiaceae, Rutaceae and Solanaceae (Weinmann, 1997).  Their structural diversity 
can greatly influence their biological activities (Kostova, 2005).  Several papers have been 
published on the antimicrobial activity of coumarins.  The antimicrobial properties of 
coumarins were first recognized in 1945 when an investigation with dicoumarol was 
conducted and it was found to inhibit the growth of several strains of bacteria (Goth, 1945).  
Smyth et al. (2009) evaluated the antimicrobial activity of 43 naturally occurring and synthetic 
coumarins against six strains of bacteria, using the MIC microtitre assay.  Approximately half 
of the coumarins tested were found to have varying antimicrobial activity with MICs ranging 
from 1.56 to >1000 μg/ml.  The antimicrobial activity of three coumarins (aesculetin, 
prenyletin and haplopinol) isolated from Haplopappus multifolius were investigated and it was 
found to inhibit the growth of three bacterial strains (Sarcina lutea, E. coli and S. aureus) with 
MICs ranging from 250 to 1000 μg/ml (Chiang et al., 1982).  
 
4.4 Conclusions 
 The plant extract of A. phylicoides (MIC range: 1 to 6 mg/ml) exhibited greater 
antimicrobial activity than the essential oil (MIC range:  3 to >32 mg/ml). 
 Greater antimicrobial activity was displayed against Gram-positive bacteria than 
Gram-negative bacteria. 
 Bioactivity guided fractionation led to the isolation of (4-hydroxyphenyl)propyl 
coumaroate. 
 (4-Hydroxyphenyl)propyl coumaroate was most active against the Gram-positive 
bacteria, S. aureus with a MIC of 19.5 µg/ml compared to a MIC of 1 mg/ml for the 
methanol extract and a MIC of 0.6 µg/ml for ciprofloxacin (positive control). 
 The MIC assay results of A. phylicoides provided preliminary evidence to support its 
use for the treatment of boils, sores, bad acne, infected wounds and cuts. 
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Chapter 5 – Anti-oxidant activity 
 
 
5.1 Introduction 
Free radicals such as hydrogen peroxide (H2O2), superoxide radicals (O2•) ۠and hydroxyl 
radicals (OH•) are unstable, highly reactive molecules.  They are produced as a normal 
consequence of biochemical processes in the body and as a result of increased exposure to 
environmental and/or dietary xenobiotics.  Free radicals are major contributors to degenerative 
diseases of aging such as cancer, cardiovascular disease, cataracts, immune system decline and 
brain dysfunction (Lee et al., 2003; Atoui et al., 2005).   
 
Anti-oxidants are free radical scavengers that inhibit the oxidative mechanisms which lead to 
degenerative diseases.  Mammalian cells possess defence mechanisms (anti-oxidant enzymes 
and small molecule anti-oxidants) for the detoxification of free radicals.  The anti-oxidant 
enzymes include superoxide dismutase (SOD), which dismutes superoxide to hydrogen 
peroxide and oxygen; catalase (CAT), which converts H2O2 into H2O and oxygen and 
gluthathione peroxidase (GPX), which destroys toxic peroxides.  In addition, small molecule 
anti-oxidants are available in vivo (gluthathione, bilirubin and melatonin) or obtained from the 
diet (α-tocopherol, β-carotene, Vitamin A and E, flavonoids, zinc and selenium) (Lee et al., 
2003). 
 
When an imbalance in oxidant and anti-oxidant processes exists (oxidative stress), the excess 
free radicals induce peroxidation of polyunsaturated fatty acids in the cell membrane lipid bi-
layer.  This causes a chain reaction of lipid peroxidation, thus damaging the cellular membrane 
and causing further oxidation of the membranes lipids and proteins.  Subsequently, cell 
contents, including DNA are damaged.  This free radical damage precedes the degenerative 
diseases (Cook and Samman, 1996; Gramza and Korczak, 2005). 
 
Traditionally, carotene, Vitamin E and C are referred to as dietary anti-oxidants.  In recent 
years there has been particular interest in the anti-oxidant activity and health benefits of other 
phytochemicals. 
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Tea is an important source of dietary polyphenols.  The types and amounts of polyphenols 
present in tea will differ dependant on the variety of leaf, growing environment, processing, 
manufacturing, particle size of ground tea-leaves and infusion preparation (Gramza and 
Korczak, 2005).  The results of many studies showed the potential anti-oxidant properties of 
polyphenols (Kähkönen et al., 1999; Miliauskas et al., 2004; Aoshima et al., 2007; Conforti et 
al., 2008).  However, the relationship between the total phenolic content and anti-oxidant 
activity are in-conclusive.  Some authors have found a correlation between the total phenolic 
content and anti-oxidant activity while others found no relationship.  Kähkönen et al. (1999) 
and Conforti et al. (2008) found no correlation between the total phenolic content and anti-
oxidant activity, and have concluded that the difference in anti-oxidant activity is attributed to 
the type of phenolic constituents and not the amount of phenolic constituents.  However, other 
authors confirm that the higher the polyphenol content, the higher the anti-oxidant activity 
(Miliauskas et al., 2004; Aoshima et al., 2007).    
 
The growing interest in the anti-oxidant activity of tea and the potential health benefits led to 
the study of the anti-oxidant activity of commercially available teas with A. phylicoides. 
 
The aims of this study were to: 
 confirm that A. phylicoides possess anti-oxidant activity. 
 compare the anti-oxidant activity of A. phylicoides to that of other commercially 
available teas. 
 
5.2 Materials and methods 
The anti-oxidant activities of rooibos tea (green and fermented), green tea, Ceylon (black) tea 
and honeybush tea were compared to A. phylicoides (Bush tea) using the 2,2-diphenyl-1-
picrylhydrazyl (DPPH•) free radical scavenging assay.  Rooibos, green, Ceylon and 
honeybush tea were purchased at a local supermarket.  Green rooibos tea was sourced from 
Rooibos Ltd in Clanwilliam and a pooled sample of A. phylicoides (Bush tea) (Figure 5.1) was 
used in the analysis.  The botanical and common names of the samples tested are listed in 
Table 5.1. 
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Figure 5.1:  Commercial packs of teas tested for anti-oxidant activity. 
 
Table 5.1:  Botanical names and common names of samples tested in DPPH• assay. 
Botanical name Common name 
Aspalathus linearis Green rooibos tea 
Aspalathus linearis (fermented) Rooibos tea 
Athrixia phylicoides Bush tea (Zulu tea) 
Camellia sinesis Green tea 
Camellia sinesis (fermented) Black tea (Ceylon) 
Cyclopia intermedia Honeybush tea 
 
5.2.1 Principle of the method 
DPPH• is a stable free radical with a dark violet colour.  Anti-oxidant compounds donate 
electrons to DPPH•, resulting in decolourization from deep violet to light yellow.  The degree 
of decolourization is proportionate to the number of electrons accepted by the DPPH• and is 
measured with a UV/VIS light spectrophotometer (Miliauskus et al., 2004). 
 
5.2.2 Protocol 
A 96 μM DPPH• solution was prepared in HPLC grade methanol and stored at 4 °C in the 
dark.  Tea extracts were dissolved in dimethyl sulfoxide (DMSO) to obtain a stock solution of 
10 mg/ml.  For the first dilution, 50 μl of the stock solution was added to 950 μl of DMSO to 
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obtain a concentration of 500 μg/ml, but following the addition of the DPPH•, there was a final 
concentration of 100 μg/ml in the well.  Six serial dilutions (1:1) were performed thereafter 
using DMSO. 
 
Using a 96-well microtitre plate, 50 μl of the stock solutions and serial dilutions was plated out 
in triplicate from rows B to G.  In row A and H, 50 μl of DMSO was added, which acted as a 
negative control.  In columns 2, 4, 6, 8, 10 & 12 HPLC grade methanol (200 μl) was added 
and in columns 1, 3, 5, 7, 9 & 11 DPPH• (200 μl) was added. L-Ascorbic acid (Vitamin C) 
was used as a positive reference. 
 
The plate was shaken for 2 minutes and left to stand for 30 minutes at room temperature.  
Thereafter, the absorbance was read at 550 nm using an UV-spectrophotometer and the 
percentage decolourization (the percentage free radical scavenging activity of the test 
compound) was calculated.  The IC50 values were calculated using Enzfitter® software.  Each 
experiment was done in triplicate and the mean and standard deviation (s.d.) reported. 
 
5.3 Results and discussion 
All the aqueous extracts showed free radical scavenging activity ranging from 9.64 µg/ml to 
29.26 µg/ml (Figure 5.2).  The results of the in vitro assay showed that green tea possessed the 
highest anti-oxidative activity (IC50 = 9.64 ± 0.96 µg/ml) and A. phylicoides (Bush tea) (IC50 = 
14.01 ± 2.68 µg/ml) had greater anti-oxidant properties than fermented rooibos tea, honeybush 
tea, green rooibos tea and Ceylon tea (IC50 > 18.00 µg/ml).  A. phylicoides was at least 2.5 
times less active than the reference compound, Vitamin C (L-Ascorbic acid). 
 
The anti-oxidant activity of the aqueous tea extracts tested in this study using the DPPH• assay 
decreased in the order:  green > A. phylicoides (Bush) > green rooibos > honeybush > 
fermented rooibos > Ceylon (black) (Figure 5.2).  These results are in agreement with a 
previous study in which the DPPH• free radical scavenging method was utilised to determine 
the anti-oxidant activity of green, rooibos (fermented, unfermented and semi-fermented), 
black and oolong tea extracts (concentration of tea extracts:  50 mg/100 ml).  The anti-oxidant 
activity and percentage inhibition was as follows:  green (90.8%) > unfermented rooibos 
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(86.6%) > fermented rooibos (83.4%) > semi-fermented rooibos (81.9%) > black (81.7%) > 
oolong (71.2%) (von Gadow et al., 1997).   
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Figure 5.2:  In vitro anti-oxidant activity of aqueous tea extracts. 
 
In another study, the DPPH• assay was utilized to determine the anti-oxidant activity of fruits, 
vegetables and teas and the amount of anti-oxidants needed to decrease the initial DPPH• 
absorbance by 50% (EC50) was determined.  It was concluded from the study that in general, 
honeybush tea (EC50 ranges from > 8000 to > 1000 μg/ml) exhibited lower anti-oxidant 
activity than green (EC50 ranges from 120 to 320 μg/ml), rooibos (EC50 ranges from 620 to 
1100 μg/ml) and black tea (EC50 ranges from 230 to 750 μg/ml) (du Toit et al., 2001).  The 
results from this study deviated with regard to anti-oxidant activity of honeybush tea from the 
du Toit et al. (2001) study (Figure 5.2).  Honeybush tea (IC50 18.02 ± 4.27 μg/ml) exhibited 
greater anti-oxidant activity than both rooibos and black tea and lower anti-oxidant activity 
than green tea. 
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According to McGaw and co-authors (2007), the decoction (50 g of dried aerial parts boiled in 
1.5 L water for 15 min) and the infusion (1.5 L of boiling water poured over 50 g of dried 
aerial parts and allowed to stand for 15 min) of A. phylicoides revealed higher anti-oxidant 
activity than A. elata in the Trolox™ equivalent anti-oxidant capacity (TEAC) assay.  In the 
same study the anti-oxidant activity of the A. phylicoides decoction was higher than rooibos 
(TEAC content: 0.269 ± 0.015 vs. 0.257 ± 0.001) and the anti-oxidant activity of the A. 
phylicoides infusion was similar to that of rooibos (TEAC content: 0.248 ± 0.012 vs. 0.257 ± 
0.001).  The comparative results from the McGaw et al. (2007) study deviates from the results 
obtained in the DPPH• assay, in which A. phylicoides (Bush tea) displayed greater anti-oxidant 
activity than fermented rooibos tea.  The difference in results can be attributed to the different 
methods utilised to determine antioxidant activity.  However, the McGaw et al. (2007) study 
supports the conclusion that A. phylicoides (Bush tea) possesses some anti-oxidant activity.   
 
In another study, the anti-oxidant DPPH• scavenging activity of the ethanol extract of A. 
phylicoides, harvested in Venda in the Limpopo Province (South Africa) in mid-July was 
investigated.  The concentration of the extract required to scavenge 50% DPPH• (EC50) was 
calculated.  The results revealed that the ethanol extract displayed some degree of anti-oxidant 
activity (EC50 = 10.64 ± 0.08 μg/ml) (Mavundza et al., 2007).  These results further supports 
the conclusion that A. phylicoides (Bush tea) possesses some anti-oxidant activity.  The 
difference in results between the aqueous extract from this study (IC50 = 14.01 ± 2.68 μg/ml) 
and the ethanol extract (EC50 = 10.64 ± 0.08 μg/ml) from the Mavundza et al. (2007) study 
can be attributed to the difference in extraction solvents used, locations from where samples 
were collected and the time of collection of samples. 
 
Previous studies have shown the potential anti-oxidant properties of polyphenols (Kähkönen et 
al., 1999; Miliauskas et al., 2004; Aoshima et al., 2007; Conforti et al., 2008).  Polyphenols 
have been found in A. phylicoides, however, no consistent correlation between the anti-oxidant 
activity and total phenolic content could be found (McGaw et al., 2007).  
 
According to Manzocco and co-authors (1998), tea exhibits a significant health protecting 
activity due to its high flavonoid content.  Flavonoids are the most abundant compounds in 
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fresh tea leaves and extracts. Flavonoids have long been recognised to have strong anti-
oxidant activity and are therefore considered to be responsible for the anticarcinogenic and 
antimutagenic properties of tea, as well as its protective action against cardiovascular disease.  
However, it is well known that the tea manufacturing processes can greatly affect the content 
of flavonoids.  Tea flavonoids are very reactive species, which can easily undergo enzymatic 
and chemical reactions, which may be responsible for changes in the anti-oxidant properties of 
the product (Manzocco et al., 1998). 
 
The anti-oxidant activity of the commercially available teas assessed in this study, are in 
agreement with the results of previous studies, in which the effects of manufacturing processes 
on anti-oxidant activity of tea extracts were investigated (von Gadow et al., 1997; Manzocco 
et al., 1998).  Green tea and green rooibos tea are produced from fresh leaves, preventing 
oxidation of flavonoids and therefore exhibit stronger anti-oxidant activity than black tea and 
fermented rooibos tea, respectively (Figure 5.2).  Both black tea and fermented rooibos tea are 
subjected to chemical modifications during processing.  The greater free radical scavenging 
activity of A. phylicoides compared to black and fermented rooibos tea can be attributed to the 
fact that A. phylicoides has not been subjected to any processing.  It is not known how A. 
phylicoides free radical scavenging activity will be affected if it is subjected to manufacturing 
processes like other commercially available teas. 
 
The literature revealed that A. phylicoides is used by the local people as a medicinal product 
and as a beverage (van Wyk and Gericke, 2000).  A recent survey conducted in a rural area in 
Limpopo and three black urban areas in Gauteng revealed that A. phylicoides is still a very 
popular beverage in the rural area and is known and utilised by some urban residents as a tea. 
It was further indicated by urban residents that A. phylicoides would be purchased to be 
enjoyed as a beverage if it was commercially available (Rampedi and Olivier, 2005).  The 
favourable anti-oxidant property of A. phylicoides, in comparison to other commercially 
available teas (Figure 5.2) supports its traditional use as a beverage. 
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5.4 Conclusions 
 A. phylicoides (bush tea) exhibited anti-oxidant activity (IC50 = 14.01 ± 2.68 µg/ml) 
against the free radical scavenging (DPPH•) assay. 
 A. phylicoides (bush tea) anti-oxidant activity was greater than unfermented rooibos 
and Ceylon (black) tea (IC50 > 25.00 µg/ml); but comparable to green rooibos and 
honeybush tea ((IC50 = 18.01 ± 4.06 µg/ml; 18.02 ± 4.27 µg/ml, respectively), but less 
than green tea (IC50 = 9.64 ± 0.96 µg/ml). 
 The in vitro anti-oxidant results of A. phylicoides against the free radical scavenging 
(DPPH•) assay provided preliminary evidence to support its use of as a health-
promoting beverage.   
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Chapter 6 – Antimalarial activity 
 
 
6.1 Introduction 
 As recent as the early 1900’s, human malaria was endemic across every continent except 
Antarctica (Girard et al., 2007).  Despite intense efforts to control and eradicate malaria, the 
disease continues to be one of the greatest health problems facing Africa.  The WHO 
estimated that at least 247 million cases of malaria occurred in 2008 with nearly one million 
deaths, mostly among children living in Africa (WHO, 2010). 
 
Malaria, transmitted by the bite of an infected female Anopheles mosquito is caused by four 
species of Plasmodium, which are P. falciparum, P. vivax, P. ovale and P. malariae (Kaur et 
al., 2009).  P. falciparum is the most dangerous of the human malaria parasites and is 
responsible for the majority of infections in Africa (Pillay et al., 2008).  The life cycle of a 
malaria parasite is presented in Figure 6.1.  Symptoms appear seven days or more (usually 10–
15 days) after exposure and include fever, headache, chills and vomiting (WHO, 2010).  
 
Although a number of advances have been made towards the understanding of the disease, the 
increasing prevalence of drug-resistant strains of P. falciparum to standard antimalarial drugs 
necessitates a continuous effort to search for new antimalarial drugs with new modes of 
action, used alone or in combination.   
 
History reveals that the majority of antimalarial drugs have been derived from medicinal 
plants.  These include the quinoline-based antimalarials such as quinine as well as artemisinin 
and its derivatives (Clarkson et al., 2004; Bourdy et al., 2008).  Since the majority of 
antimalarials originated from plants, an investigation of the chemical components of 
traditional medicinal plants could lead to the development of new antimalarial drugs.  South 
Africa with its rich diversity of plants is an ideal place to screen plants for antiplasmodial 
activity (van Wyk, 2008).  The mortality of malaria and therefore the pressing need to 
discover new antimalarials substantiates the investigation of A. phylicoides for antiplasmodial 
activity. 
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Figure 6.1:  The life cycle of the malaria parasite 
(http://www.emro.who.int/rbm/Images/MalariaLifeCycle-1.gif). 
 
The aim of this study was to investigate the essential oil and methanol extract of the 
indigenous plant A. phylicoides for potential antiplasmodial activity. 
 
6.2 Materials and methods 
 
6.2.1 Parasite suspension 
The parasites were grown continuously in culture medium and maintained at a 5 – 10% 
haematocrit.  The culture medium consists of Roswell Park Memorial Institute media (RPMI-
1640), HEPES buffer (N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid), D-glucose, 
hypoxathine, gentamicin, 5% (w/v) NaHCO3 and 10% (v/v) heat-inactivated human plasma 
(Desjardin et al., 1979).  The stock culture was adjusted to a haematocrit of 1% and 
parasitemia of 0.5% for addition to the microtitre plates. 
 
6.2.2 Tritrated hypoxanthine incorporation assay 
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The antimalarial activity of the methanol extract and essential oil of A. phylicoides was 
assessed in vitro on the chloroquine-resistant Plasmodium falciparum (FCR-3) strain using the 
tritrated hypoxanthine incorporation assay (Desjardin et al., 1979; van Zyl et al., 2006) in 
collaboration with Dr RL van Zyl, Department of Pharmacy and Pharmacology, University of 
Witwatersrand. 
 
6.2.3 Principle of the method 
The human malaria parasite P. falciparum was exposed to different concentrations of the test 
compounds for a single cycle of parasite growth (48 hours).  The in vitro uptake of [3H]-
hypoxathine by malaria parasites was used as an indicator of parasite growth.  Hypoxanthine 
is required by the parasites for their DNA synthesis and is only supplied by the human host.  
The standard antimalarial, quinine was used as a positive control.  
 
6.2.4 Protocol 
The methanol extract was dissolved in DMSO to make a stock solution of 10 mg/ml, 
subsequent dilutions made in experimental medium (RMPI-1640, glucose and HEPES buffer).  
The essential oil (10 μl) was diluted with 90 μl of DMSO to make a stock solution of 10%; 
whilst quinine (control) was dissolved in the experimental medium. 
 
For each dilution, 25 μl (extract or control) or 2 μl (essential oil) of the various dilutions were 
plated out in triplicate in a 96-well plate.  To ensure a total of 25 μl per well, 23 μl 
experimental medium was added to the wells containing essential oils.  The parasite 
suspension 200 μl was then added to each well.  Untreated parasites in eight wells and 
uninfected red blood cells in four wells were used as controls. 
 
After preparation, the plates were placed in a humidified airtight candle jar with a gaseous 
atmosphere of 5% O2, 5% CO2 and 90% N2.  The candle jar was then incubated at 37 °C for 
24 hours.  Following incubation, 25 μl of [3H]-hypoxanthine was added to each well.  The 
plate was then returned to the candle jar and incubated for a further 18 hours at 37 °C.  After 
the second incubation, parasitic 3H-DNA was harvested on glass fiber filter mats with a cell 
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harvester.  The filter mats were dried and the incorporated [3H]-hypoxanthine was counted 
with a liquid scintillation counter.   
 
The inhibitory effects of the test compounds were expressed as percentage parasite growth of 
untreated parasitised and erythrocyte controls.  The percentages were plotted against their 
respective concentrations and the log sigmoid dose-response curve was constructed using the 
Enzfitter® software.  The IC50 values (the concentration required to kill 50% parasite) 
determined from the log sigmoid dose-response curve was calculated as a measure of the 
antimalarial activity of the solvent extract and essential oil.  The experiment was repeated four 
times for each test compound and the mean and standard deviation reported. 
 
6.3 Results and discussion 
The methanol extract of A. phylicoides displayed no significant in vitro activity against the 
chloroquine-resistant P. falciparum (FCR-3) strain (IC50 value = 83.489 ± 5.482 μg/ml).  
However, the essential oil showed promising in vitro activity against the chloroquine-resistant 
P. falciparum (FCR-3) strain (IC50 value = 1.006 ± 0.06 μg/ml) when compared to the control 
quinine (0.034 ± 0.002 μg/m) (Table 6.1). 
 
Table 6.1:  In vitro antimalarial activity of A. phylicoides.  
Sample Antimalarial activity:  IC50 ± s.d. (μg/ml) n 
Methanol extract  83.489 ± 5.482 4 
Essential oil  1.006 ± 0.06 4 
Quinine  0.034 ± 0.002 6 
    
Malaria is a major health problem and new treatments are urgently needed to curb and 
eradicate this endemic.  As a result antimalarial studies have been performed on several plants 
indigenous to South Africa (Prozesky et al., 2001; Clarkson et al., 2004).  To date no data has 
been published on the antimalarial activity of A. phylicoides. 
 
The antimalarial activity in this study varied greatly between the essential oil and methanol 
extract (Table 6.1).  The essential oil showed good antimalarial activity (1.006 ± 0.06 μg/ml).  
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According to Clarkson and co-authors (2004), solvent extracts with an IC50 value ≤10 μg/ml 
were classified as having promising antimalarial activity.  Therefore it can be concluded that 
the methanol extract exhibited poor antimalarial activity (IC50 value = 83.489 ± 5.482 μg/ml). 
 
Physical properties of essential oils, including low density (∼0.94 g/ml) and the ability to 
readily diffuse across cell membranes (Boyom et al., 2003) may partly explain why the 
essential oil is more active than the methanol extract. 
 
It has been reported that sesquiterpenoids and their derivatives possess numerous biological 
properties, including antimalarial activity (Boyom et al., 2003; Kamatou et al., 2005).  In a 
study on antimalarial use of the volatile oil from leaves of Virola surinamensis (Rol.) Warb, 
nerolidol (an acyclic oxygenated sesquiterpene) was identified as one of the active constituents 
(Lopes et al., 1999).  α-Pinene (IC50 = 1.2 ± 0.2 μM) and (E & Z)–(±)-nerolidol (IC50 = 0.9 ± 
0.3 μM) have been reported to have potent antimalarial activity (van Zyl et al., 2006).  In 
literature, the antimalarial activity of essential oils of other plant species have been reported 
frequently.  Kamatou and co-authors (2005) reported that the essential oils of Salvia species 
displayed good antimalarial activity against the chloroquine-resistant P. falciparum (FCR-3) 
strain (IC50 values ranged from 1.23 ± 0.31 to 4.38 ± 1.07 μg/ml).  Lippia multiflora exhibited 
similar antimalarial activity against the chloroquine-resistant (FcB1) and chloroquine-sensitive 
(F32) strains of P. falciparum (Valentin et al., 1995).  Nerolidol and linalool were thought to 
be the constituents responsible for the antimalarial activity of the essential oil of L. multiflora.  
Boyom et al. (2003) investigated the antimalarial activity of H. crispiflorus against P. 
falciparum and found that the oils were also active (IC50 = 2.0 μg/ml). 
 
Athrixia phylicoides essential oil samples studied consists of the following major 
sesquiterpenoids and their derivatives in varying quantities:  caryophyllene oxide (1.0 – 
34.2%); spathulenol (1.5 – 12.6%); germacrene D (trace amounts – 13.5%); β-caryophyllene 
(0.2 – 11.9%) (Figure 3.3).  The acyclic oxygenated sesquiterpene, (E)-nerolidol is also 
present in trace amounts in some samples.  In addition, the monoterpene α-pinene (0.8 – 
14.8%), which has previously, exhibited antimalarial activity (IC50 = 1.2 ± 0.2 μM) (van Zyl et 
al., 2006) is also present (Table 3.1).  From the literature review it can be concluded that these 
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constituents of the essential oil could contribute to the overall antimalarial activity of A. 
phylicoides.  These preliminary studies on the antimalarial activity of the essential oils can 
contribute towards the discovery of agents which may assist with prophylaxis of malaria.   
However, further in vitro and in vivo studies are required to understand the mechanism of 
action of the essential oil. 
 
6.4 Conclusions 
 The essential oil of A. phylicoides exhibits antimalarial activities against the 
chloroquine-resistant Plasmodium falciparum (FCR-3) strain (IC50 = 1.006 ± 0.06 
μg/ml). 
 The methanol extract of A. phylicodes exhibits poor antimalarial activities against 
chloroquine-resistant Plasmodium falciparum (FCR-3) strain (IC50 = 83.489 ± 5.482 
μg/ml). 
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 Chapter 7 – Anti-inflammatory activity
 
 
7.1 Introduction 
Inflammation is the body’s reaction in response to injury, infections, chemicals and poisons 
and is characterized by redness, swelling, heat and pain.  The inflammatory response has 
survival value but if inappropriately deployed, as occurs in many diseases, may be deleterious.  
For this reason it is essential to understand the process of inflammation and the mediators 
responsible for this process (Dale and Haylett, 2004). 
 
Two important groups of mediators responsible for the inflammatory response are 
prostaglandins and leukotrienes.  The pathway by which prostaglandins are formed, can be 
inhibited by non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and aspirin 
that inhibit the cyclooxygenase enzyme (Figure 7.1).  These drugs are commonly utilized for 
the management of diseases associated with inflammation such as rheumatoid arthritis, 
oesteoarthritis, acute bursitis and tendonitis (Dale and Haylett, 2004). 
 
The use of NSAIDs for the management of these diseases provides more substrate for the 
alternate pathway of the arachidonic acid casade (Figure 7.1), in which the 5-lipoxygenase 
enzyme converts arachidonic acid into biologically active leukotrienes.  Leukotrienes are the 
major pathophysiological mediators of the inflammatory response, since they are more potent 
than the prostagladins with regard to the increase in vascular permeability, adhesion of 
leukocytes to the vessel wall and oedema production.  Leukotrienes mediate the inflammatory 
response, which can lead to various diseases, such as asthma, inflammatory bowel disease and 
allergic rhinitis.  It is therefore essential to discover compounds that can inhibit the 5-
lipoxygenase enzyme.  A study conducted on South African medicinal plants revealed that 
some plants such as the aqueous extract of Melianthus comosus (IC50 = 13.84 ppm) and the 
essential oil of Ballota africana (IC50 = 29.99 ppm) exhibited 5-lipoxygenase inhibitory 
activity when compared to the control, nordihydroguaiaretic acid (NDGA) (IC50 = 5.0 ppm) 
(Frum and Viljoen, 2006). 
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Figure 7.1:  Inflammatory cascade, where PG is prostaglandins, LT is leukotrienes, TXA2- 
thromboxane and HPETE is hydroperoxyeicosatetraenoic acid (Dale and Haylett, 2004). 
                     
It was reported that a decoction or strong tea of A. phylicoides leaves has been used in 
traditional medicine by Sotho speaking people to treat sore feet, and the leaves are chewed by 
Sotho and Xhosa speaking people to treat sore throats (Table 1.2) (Watt and Breyer-
Brandwijk, 1962; Roberts, 1990; Hutchings et al., 1996).  These traditional uses imply that the 
indigenous plant may possess anti-inflammatory activity.   
 
The aim of this study was to determine whether the non-volatile compounds and the essential 
oil of A. phylicoides possess anti-inflammatory activity by specifically inhibiting the 5-
lipoxygenase enzyme. 
 
PHOSPHOLIPIDS 
ARACHIDONIC ACID 
CYCLIC  
ENDOPEROXIDES 
5-HPETE 
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7.2 Materials and methods 
The anti-inflammatory activity of the essential oil and methanol extract of A. phylicoides was 
performed in vitro using the 5-lipoxygenase assay of Sicar et al. (1983) as modified by Evans 
(1987). 
 
7.2.1 Principle of the method 
5-Lipoxygenase is known to catalyse the oxidation of unsaturated fatty acids containing 1,4-
pentadiene structures.  In the body, arachidionic acid (biological substrate) is oxidized to 
hydroperoxyeicosatetraenoic acid (HPETE’s) by the 5-lipoxygenase.  In the in vitro assay, 
linoleic acid is used as the substrate for 5-lipoxygenase enzyme.  Linoleic acid is oxidized in 
vitro to a conjugate diene by 5-lipoxygenase, which absorbs at 234 nm.  5-Lipoxygenase 
activity is evaluated by the spectrophotometric measurement of the conjugated diene at 234 
nm.  The initial reaction rate was measured with the UV-VIS spectrophotometer and the 
decrease of this initial reaction rate is a measure of the sample’s inhibitory activity (Baylac 
and Racine, 2003). 
 
7.2.2 Protocol 
The test compounds were dissolved in DMSO and Tween® 20 to achieve a starting 
concentration of 100 μg/ml.  The potassium phosphate buffer (pH 6.3) was prepared by 
mixing 50 ml of 0.1 M potassium dihydrogen phosphate and 9.7 ml of 0.1 M sodium 
hydroxide.   
 
In a 3 ml cuvette maintained at 25 °C in a thermostated bath, 10 μl of the test compound 
dissolved in DMSO and Tween® 20 was mixed with 2.95 ml of pre-warmed potassium 
phosphate buffer (pH 6.3) and 45 μl of linoleic acid (≥ 99%) from Fluka.  Thereafter 100 U of 
the 5-lipoxygenase (enzyme) diluted in an equal volume of ice-cold potassium phosphate 
buffer (pH 6.3) (stored at 4 °C), was added to the cuvette to initiate the enzymatic reaction.  
The same mixture was prepared as above, but only with DMSO and Tween® 20 (no test 
sample) to act as a negative control. 
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The inhibitory activity of the test compounds on the enzyme was assessed by recording the 
absorbance using a UV-VIS spectrophotometer at 234 nm, of the conjugated diene formed 
from linoleic acid.  The initial reaction rate was determined from the slope of the straight line 
portion of the curve.  The percentage inhibition of enzyme activity was calculated by 
comparison with the negative control.  The concentration that gave 50% inhibition (IC50) was 
calculated using Enzfitter® software.  Nordihydroguaiaretic acid was used as a positive control 
in this assay. 
 
7.3 Results and discussion 
Results obtained for the 5-lipoxygenase assay for the methanol extract and essential oil of A. 
phylicoides were quite contrasting. The essential oil displayed in vitro 5-lipoxygenase 
inhibitory activity with an IC50 value of 25.68 µg/ml, whereas the methanol extract was found 
to be inactive at the starting concentration of 100 µg/ml (IC50 > 100 µg/ml).  The positive 
control, NDGA inhibited enzyme activity at an IC50 value of 5.0 µg/ml.  Only one test was 
performed for both the essential oil and methanol extract due to insufficient quantities of 
samples remaining after the completion of all other assays.  
 
An essential oil with a 10 ≤ IC50 ≤ 30 ppm (= µg/ml) is defined as a good 5-lipoxygenase 
inhibitor (Baylac and Racine, 2003).  Therefore, it can be concluded that the essential oil of A. 
phylicoides is a good 5-lipoxygenase inhibitor (IC50 = 25.68 µg/ml).  
 
Essential oil constituents, terpenic hydrocarbons (d-limonene, 10 ≤ IC50 ≤ 30 ppm (= µg/ml) 
and α-pinene, 31 ≤ IC50 ≤ 50 ppm (= µg/ml)) and sesquiterene hydrocarbons (β-caryophyllene 
and germacrene D, 10 ≤IC50 ≤ 30 ppm (= µg/ml)) exhibited inhibitory activity against the 5-
lipoxygenase enzyme (Baylac and Racine, 2003).  These compounds could have contributed to 
the overall anti-inflammatory activity of A. phylicoides since they were present in varying 
concentrations in most samples studied (limonene:  0.7% to 4.0%; α-pinene:  0.8% to 14.8%; 
β-caryophyllene:  0.2% to 11.9%; germacrene D:  trace amounts to 13.5%) (Table 3.1).   
 
Traditionally the leaves of A. phylicoides are chewed for the treatment of sore throats and a 
decoction or strong tea of A. phylicoides is used for bathing of sore feet (Table 1.2).  The 
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chewing of the plant can result in the release of the essential oils from the plant.  The in vitro 
result obtained from this study confirms that the essential oil of A. phylicoides inhibits the 5-
lipoxygenase enzyme, providing scientific evidence to justify its traditional use. 
 
It is important to note that the absence of 5-lipoxygenase inhibitory activity of the methanol 
extract of A. phylicoides does not necessarily imply that the extract is devoid of any anti-
inflammatory activity.  The activity may be observed at concentrations greater than 100 µg/ml 
as assayed in this study.  The inflammatory cascade (Figure 7.1) is very complex and the 
extract may exert pharmacological effects on other target sites of the cascade, such as the 
cyclooxygenase enzyme or phospholipase A2 enzyme.  Therefore further studies (e.g. COX-1, 
COX-2 and phospholipase A2 inhibition studies) are required to confirm whether or not the 
extract of A. phylicoides displays inhibitory activity at any of the other target sites of the 
inflammatory cascade. 
 
7.4 Conclusions 
 The essential oil exhibited inhibitory activity against the 5-lipoxygenase enzyme (IC50 
= 25.68 µg/ml). 
 The methanol extract was inactive against the 5-lipoxygenase enzyme at a 
concentration of 100 µg/ml. 
 The in vitro anti-inflammatory results of the essential oil of A. phylicoides against the 
5-lipoxygenase enzyme, provided preliminary evidence to support its use as a 
treatment of sore feet and sore throats. 
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Chapter 8 – Cytotoxicity 
 
 
8.1 Introduction 
Herbal remedies are rapidly gaining popularity throughout the world as a result of 
dissatisfaction with conventional medicines.  It is a widely held belief that herbal preparations 
are "natural" and are therefore intrinsically harmless (Bateman et al., 1998).  In South Africa, 
traditional or herbal remedies form a significant part of day-to-day living.  While many 
traditional remedies may be of benefit, some may have little or no effect, and others may be 
cytotoxic.  Cytotoxicity is a measure of toxicity of a substance to living cells of the human 
body.  Cytotoxicity of herbal remedies may be attributed to several factors such as 
hepatotoxicity of main constituents, contamination of preparations by heavy metals or micro-
organisms, and adverse reactions due to age, and genetic and concomitant disease 
characteristics of the user (Bateman et al., 1998).  Some classical examples of plants that are 
toxic to humans include foxglove, poison hemlock and aconite (Wittstock and Gershenzon, 
2002). 
 
In South Africa, the process for registration and use of conventional medicines is clearly 
defined and all medicines must have proven quality, safety and efficacy.  However traditional 
remedies are not subjected to the same process.  Therefore, the potential toxicity of traditional 
remedies becomes an important consideration when studying the traditional use of plants.  
Very little information is available in the literature on the safety and toxicity of A. phylicoides, 
in contrast to other commercially available teas such as rooibos tea and honeybush tea.  A 
number of studies have addressed aspects of safety and toxicity of rooibos and honeybush, for 
example, it was reported that in a ten week study, chronic consumption of rooibos and 
honeybush by rats did not cause any adverse effects in the kidney or liver (Marnewick et al., 
2003).  Several studies have also addressed tea-drug interactions (Jang et al., 2004; Mertens-
Talcott et al., 2006; Matsuda et al., 2007).  The lack of toxicity data for the volatile oils of A. 
phylicoides and the pharmacological activities displayed in the previous Chapters prompted 
the investigation of the cytotoxicity properties to determine whether A. phylicoides is safe for 
consumption. 
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The aim of this study was to: 
 evaluate the cytotoxic properties of the essential oil and methanol extract of A. 
phylicoides. 
 
8.2 Materials and methods 
 
8.2.1 Microculture tetrazolium cellular viability assay 
The cytoxicity properties of the methanol extract and essential oil of A. phylicoides was 
assessed on human kidney epithelial cells using the microculture tetrazolium cellular viability 
assay, in collaboration with Dr RL van Zyl, Department of Pharmacy and Pharmacology, 
University of Witwatersrand (Mosmann, 1983; van Zyl et al., 2006).   
 
8.2.2 Principle of the method 
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) is a tetrazolium 
dye which is used to measure the cellular conversion of the dye into an insoluble formazan 
product by active mitochondria of living cells.  The conversion of MTT to the insoluble 
compound is monitored by a shift in absorbance.  The amount of formazan produced is 
directly proportional to the number of active cells.  The MTT assay evaluates cellular viability 
in the presence of a test compound. 
 
8.2.3 Protocol 
The human kidney epithelial cells were maintained in culture medium consisting of HAM 
F10, 5% (v/v) foetal calf serum (FCS) and 0.5 mg/ml gentamicin sulphate.  HAM F10 solution 
consists of HAM F10 medium (9.38 g) and NaHCO3 (1.18 g) in a total volume of one litre of 
sterile MilliQ™ water.  The culture medium was replaced three times a week.  Once the cells 
reached confluency, they were trypsinised with 4 ml of 0.25% Trypsin containing EDTA 
(0.1%) to obtain a single cell suspension.  The cells were centrifuged at 1500 rpm for 5 
minutes to remove the trypsin.  Once the cells were resuspended in experimental medium, 1 
ml was used to seed a new culture and the remaining was used in the MTT assay.  The 
experimental medium was prepared the same way as the culture medium except no gentamicin 
sulphate was included.  The trypsinised cell suspension (50 μl) was stained with an equal 
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volume of Trypan blue (0.2% w/v) and the number of cells were counted using a 
haemocytometer.  The experimental medium was used to adjust the cell suspension (≥ 95% 
cell viability) to 0.25 million cells/ml. 
 
The methanol extract were dissolved in DMSO to make a stock solution of 10 mg/ml. 
Subsequent dilutions were made in experimental medium.  The essential oil (10 μl) was 
diluted with 90 μl of DMSO to make a stock solution of 10% and subsequent dilutions were 
made in DMSO.  Quinine (negative control) was dissolved in the experimental medium. 
 
Kidney epithelial cell suspension (180 μl) was plated out in a 96-well plate and incubated at 
37 °C for six hours to allow the cells to adhere to the well.   For each dilution, 20 μl (extract or 
control) or 2 μl (essential oil) of the various dilutions were plated out in triplicate in a 96-well 
plate.  To ensure a total of 200 μl per well, 18 μl experimental medium was added to the wells 
containing essential oils.  Each plate contained 10 wells for the untreated cell control and two 
wells for the blank cell-free control.  The plates were incubated in 5% CO2 at 37 °C.  After 44 
hours of incubation 40 μl of MTT (12mM) was added to each well and re-incubated for further 
four hours.  The supernatant (180 μl) was removed from each well and replaced with 150 μl of 
DMSO to stop the reaction and to solubilise the formazan crystals.  The plates were shaken for 
four minutes and the absorbance was read at a test wavelength of 540 nm and a reference 
wavelength of 690 nm.  The results were expressed as percentage cellular viability of the drug 
and cell-free controls.  The percentage cellular viability data was plotted against their 
respective concentrations and log sigmoid dose-response curves were generated by the 
Enzfitter® software.  The concentration which inhibits 50% of cellular growth (IC50 value) was 
determined from the log sigmoid dose-response profile.  The experiment was repeated four 
times and the mean and standard deviation (s.d.) calculated.  Quinine, a plant -derived 
compound considered to be relatively safe, was used as a negative control.   
 
The safety index relates the dose of the drug required to produce a desired effect to that which 
causes an undesired effect.  The toxicity of the methanol extract and essential oil was 
compared to their antimalarial activity, using the safety index Equation 1. 
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Equation 1 
 
8.3 Results and discussion 
The toxicity of the methanol extract and essential oil of A. phylicoides was assessed using the 
MTT assay and the results obtained are presented in Table 8.1.  The essential oil proved to be 
more toxic than the methanol extract.  The safety indices of the samples and control were 
calculated and are presented in Table 8.1.  The safety index of the control, quinine (SI = 
4001.74) was appreciably higher than the methanol extract (SI = 2.28) and the essential oil (SI 
= 1.77).  The low safety indices of the methanol extract and the essential oil implied that they 
have low degrees of selectivity for P. falciparum.   
 
Table 8.1:  In vitro cytotoxic properties of A. phylicoides.  
Sample Toxicity:   
IC50 ± s.d. (μg/ml) 
n Antimalarial activity 
IC50 ± s.d. (μg/ml) 
Safety index 
(SI) 
Methanol extract  189.893 ± 12.658 4 83.489 ± 5.482 2.28 
Essential oil  1.776 ± 0.2298 4 1.006 ± 0.06 1.77 
Quinine  136.059 ± 4.057 6 0.034 ± 0.002 4001.74 
 
The cytotoxicity of the extract of A. phylicoides had been investigated in two in vitro studies 
and one in vivo study.  McGaw et al. (2007) investigated the cytotoxicity of the A. phylicoides 
against the Vero monkey kidney cell line (MTT assay) and brine shrimp eggs (Solis et al., 
1993 method) and the concentration required to kill 50% of cells (LC50) was calculated.  It 
was found that the ethanol extract displayed low toxicity (Vero cell: LC50 = 252 μg/ml and 
Brine shrimp:  LC50 = 394 μg/ml) and the aqueous preparations (i.e. aqueous extract, decoction 
and infusion) had no effect on either assay method.  In another study using the sodium 3’-[1-
(phenylaminocarbonyl)-3,4-tetrazolium]-bis-(4-methoxy-6-nitro) benzene sulfonic acid 
hydrate (XTT) colorimetric assay, the cytotoxicity of the ethanol extract against Vero cells 
lines was investigated.  The extract displayed low toxicity (IC50 = 107.8 ± 0.13 μg/ml) 
Safety Index = Toxicity 
                        Activity 
 62
(Mavundza et al., 2010).  Chellan et al. (2008) investigated the effect of high doses of aqueous 
extract of A. phylicoides (30 to 180 mg) on Wistar rats for a period of three months.  No 
mortality or morbidity was reported.  Histopathology showed no signs of any extract induced 
toxicity in the liver, kidneys or gastrointestinal tract and all laboratory results (serum alkaline 
phosphatase, creatinine and urea levels) were normal.   
 
No data has been published on the cytotoxicity of the essential oils of A. phylicoides.  The 
essential oil is about 77 times more toxic than the control, quinine and has a low safety index 
of 1.77.  The essential oil composition in Table 3.1 was evaluated to identify compounds 
possibly contributing to the toxic effects noted.  Caryophyllene oxide has been reported to 
have cytotoxic activity (LC50 values range from 147 to 351 μM) (Sibanda et al., 2004).  The 
cytotoxicity of P. serrulata essential oil can be partly explained by the presence of α-
humulene, caryophyllene oxide, γ-elemene and δ-elemene (Jie et al., 2007).  In a study 
conducted by van Zyl et al. (2006), it was reported that α-pinene (IC50 = 172.2 ± 13.4 μM), β-
pinene (IC50 = 166.7 ± 19.6 μM), (E- & Z-)-(±)-nerolidol (IC50 = 5.5 ± 1.2 μM) and 1,8-
cineole (IC50 = 69.1 ± 9.4 μM) displayed some degree of toxicity.  Caryophyllene oxide, α-
pinene and β-pinene have been identified as major constituents of the essential oil (Figure 3.3).  
Nerolidol, α-humulene and 1,8-cineole are either present in trace amounts or very small 
percentages in some of the samples studied (Table 3.1).  It can therefore be assumed that 
caryophyllene oxide, α-pinene and β-pinene together with the minor constituents (nerolidol, α-
humulene and 1,8-cineole) synergistically contribute to the cytotoxicity of the essential oil.   
 
The cytotoxicity of the essential oil was compared to the antimalarial results in Table 6.1.  The 
results from the MTT assay suggest that the antimalarial activity (Table 6.1) of the essential 
oil may be due to general cytotoxic effects and this was further supported by the low safety 
index of the essential oil (SI = 1.77).  This implied that the essential oil had a greater affinity 
for human kidney epithelial cells than for P. falciparum.   
 
The extensive traditional use of A. phylicoides aqueous extracts as a tea and medicine (Table 
1.2) and the lack of adverse effects published in the literature (van Wyk and Gericke, 2000; 
Olivier and De Jager, 2005; Rampedi and Olivier, 2005), may be an indication of the lack of 
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toxicity of this species. This hypothesis that A. phylicoides is unlikely to be toxic was 
supported by the studies conducted by McGaw et al. (2007) and Chellan et al. (2008).  
However, further in vivo testing is needed to confirm the safety profile of A. phylicoides. 
 
8.4 Conclusions 
 The essential oil of A. phylicoides (IC50 = 1.776 ± 0.2298 μg/ml) is more toxic than 
the methanol extract (IC50 = 189.893 ± 12.658 μg/ml). 
 Both the essential oil (SI = 1.77) and methanol extract (SI = 2.28) of A. phylicoides 
have low safety indices.   
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Chapter 9 – General Conclusions and Recommendations
 
9.1 Summary 
For centuries eastern countries have been using herbal remedies in the form of teas to treat 
infections, ailments and diseases, however, in recent years herbal teas have gained popularity 
in western countries for their health-related properties, including antimicrobial activity and 
anti-oxidant activity (Almajano et al., 2008; Chan et al., 2010).  One of the most beneficial 
effects of tea is its anti-oxidant activity.  Anti-oxidants play a role in the prevention of 
cardiovascular disease, cancers and neurodegenerative diseases (Kris-Etherton et al., 2002).  
As such research on teas and their effects on human health have intensified.  This report 
focused on the health-related properties as well as the toxicity of A. phylicoides.   
 
The results of the in vitro biological activities and the compounds identified in this study are 
given in Table 9.1.  The methanol extract of A. phylicoides was found to be more active 
against the micro-organisms tested compared to the essential oil; whereas the essential oil 
displayed greater antimalarial and anti-inflammatory activity compared to the methanol extract 
(Table 9.1).  The essential oil was also found to be more toxic when compared to the methanol 
extract of A. phylicoides (Table 9.1).  The aqueous extract of A. phylicoides exhibited anti-
oxidant activity comparable to that of commercially available teas (green, green rooibos, 
honeybush, rooibos and Ceylon) (Table 9.1).  Seven major compounds (>10%) were identified 
in the essential oil and one bioactive compound was identified in the methanol extract of A. 
phylicoides.  The bioactive compound was found to be 24 to 51 times more active against 
micro-organisms tested compared to the methanol extract of A. phylicoides (Table 9.1).   
 
This report is the first consolidated report in which the essential oil composition and the 
biological activities of both the essential oil and methanol extract of A. phylicoides has been 
investigated.  It has revealed that Athrixia phylicoides possesses antimicrobial, anti-oxidant 
anti-inflammatory and antimalarial activity.  As such this report paves the way for the 
successful marketing of A. phylicoides against the commonly known rooibos and honeybush 
tea. 
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9.2 Recommendations for future work 
 It is recommended that a seasonal and geographical variation study is performed on A. 
phylicoides to explain the variations in essential oil composition noted in the samples 
studied. 
 The chemotypic variation be investigated for solvent extracts using liquid 
chromatography and HPLC. 
 Since the anti-inflammatory activity was only performed on one sample, it is 
recommended that the assay be repeated to confirm the results obtained in this report. 
 A study on the anti-oxidant activity of the essential oil and methanol extract should be 
performed to obtain a complete anti-oxidant profile of A. phylicoides. 
 Since the aqueous extract was only tested for anti-oxidant activity, to obtain a complete 
profile the other assays conducted in this study should be done. 
 Studies should be performed to identify the active compounds responsible for anti-
inflammatory and antimalarial activity, and toxicity of the essential oil of A. 
phylicoides and for the anti-oxidant activity of the aqueous extract of A. phylicoides. 
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Table 9.1:  Summary of the phytochemistry and in vitro biological activities of the essential oils and extracts of A. phylicoides. 
 Antimicrobial 
activity  MIC 
range 
(mg/ml) 
Anti-oxidant activity 
(μg/ml) 
Antimalarial 
activity  
(μg/ml) 
Anti-
inflammatory 
activity 
(μg/ml) 
Cytotoxicity 
(μg/ml) 
Compounds 
identified 
A. phylicoides 
essential oil 
Gram +ve bacteria:  
3 to >32. 
Gram –ve bacteria:  
12 to >32. 
Yeasts:  4 to 6. 
ND 1.006 ± 0.06 25.68 1.776 ± 0.2298 
 
Major compounds 
(>10%):  
caryophyllene 
oxide, spathulenol, 
germacrene D, 
β-caryophyllene, 
β-pinene, α-pinene 
and myrcene 
A. phylicoides 
methanol 
extract 
Gram +ve bacteria:  
1 to 4. 
Gram –ve bacteria:   
3 to >6. 
Yeasts:  1.5 to 2. 
 
ND 83.489 ± 5.482 >100 189.893 ± 12.658 
 
(4-
Hydroxyphenyl) 
propyl coumaroate 
(4-
Hydroxyphenyl) 
propyl 
coumaroate 
Gram +ve bacteria:  
0.0195  
Gram –ve bacteria:   
0.125  
Yeasts:  0.078  
 
ND ND  ND ND ND 
Aqueous tea 
extracts 
ND Green: 9.64 ± 0.96 
A. phylicoides: 14.01 ± 
2.68 
Green rooibos: 18.01 ± 
4.06 
Honeybush: 18.02 ± 4.27 
Rooibos: 25.83 ± 2.39 
Ceylon:  29.26 ± 2.68 
ND  ND ND ND 
ND:  Not determined; Gram +ve:  Gram-positive; Gram –ve:  Gram-negative 
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Appendix A:  NMR data for the (4-hydroxyphenyl)propyl coumaroate. 
 
 
Table A.1:  NMR data (in CDCl3 + CD3OD) of the compound isolated from A. phylicoides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CD3OD: methanol; CDCl3: chloroform; d: doublet; t: triplet, δC: carbon shift;  δH: proton shift; J: coupling 
constant; Hz: hertz. 
* Assignment may be interchanged. 
 
Position δC δH 
1 30.9* 2.62 (2H, t, J 7.5 Hz) 
2 30.9 * 1.94 (2H, quintet, J 7.3 
Hz) 
3 64.2 4.14 (2H, t, J 6.5 Hz) 
1’ 132.6  
2’ 129.7 7.00 (2H, d, J 8.5 Hz) 
3’ 115.5 6.72 (2H, d, J 8.6) 
4’ 155.3  
5’ 115.5 6.72 (2H, d, J 8.6) 
6’ 129.7 7.00 (2H, d, J 8.5 Hz) 
1” 126.3  
2” 130.4 7.40 (2H, d, J 8.7 Hz) 
3” 116.2 6.80 (2H, d, J 8.7 Hz) 
4” 159.9  
5” 116.2 6.80 (2H, d, J 8.7 Hz) 
6” 130.4 7.40 (2H, d, J 8.7 Hz) 
α 114.7  
β 145.6 7.56 (1H, d, J 16.0 Hz) 
=O 168.6  
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Figure A.1:  The NMR carbon spectra (1H) for (4-hydroxyphenyl)propyl coumaroate.
 79
 
Figure A.2:  The NMR carbon spectra (13C) for (4-hydroxyphenyl)propyl coumaroate. 
